key updates for week 23, ending june 6, 2020 virus › ... › pdf › covidview-06-12-2020.pdfjun...

Nationally, levels of influenza-like illness (ILI) and COVID-19-like illness (CLI) continue to decline or remain stable at low levels. The percentage of specimens testing positive for SARS-CoV-2, the virus that causes COVID-19, increased slightly from last week. Mortality attributed to COVID-19 also decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed.

Key Updates for Week 23, ending June 6, 2020

The overall percentage of respiratory specimens testing positive for SARS-CoV-2 increased slightly from week 22 (6.0%) to week 23 (6.3%) nationally driven by increases in four regions. National percentages by type of laboratory:

• Public health laboratories – decreased from 5.8% during week 22 to 5.0% during week 23; • Clinical laboratories – decreased from 5.5% during week 22 to 5.3% during week 23; • Commercial laboratories – increased from 6.1% during week 22 to 6.5% during week 23.

Two surveillance indicators are being used to track outpatient or emergency department (ED) visits for illness with symptoms compatible with COVID-19.

• Nationally, the percentages of visits for ILI and CLI decreased or remained stable at low levels, compared to last week. Levels of ILI are below baseline nationally for the eighth week and in all 10 surveillance regions for the past six to nine weeks.

Recent changes in health care seeking behavior, including increasing use of telemedicine, recommendations to limit emergency department (ED) visits to severe illnesses, and increased practice of social distancing, are likely affecting data reported from both networks, making it difficult to draw conclusions at this time. Tracking these systems moving forward will give additional insight into illness related to COVID-19.

Cumulative COVID-19-associated hospitalization rates since March 1, 2020, are updated weekly. The overall cumulative COVID-19 hospitalization rate is 89.3 per 100,000, with the highest rates in people aged 65 years and older (273.8 per 100,000) and 50-64 years (136.1 per 100,000).

Based on death certificate data, the percentage of deaths attributed to pneumonia, influenza or COVID-19 (PIC) decreased from 12.4% during week 22 to 7.3% during week 23 but remained above baseline. This is the seventh week of a declining percentage of deaths due to PIC, but this percentage may change as more death certificates are processed, particularly for recent weeks.

Virus

Outpatient and Emergency Department Visits

Severe Disease

Public Health, Commercial and Clinical Laboratories

Outpatient Influenza-Like Illness Network (ILINet) and National Syndromic Surveillance Program (NSSP)

Hospitalizations Mortality

All data are preliminary and may change as more reports are received. A description of the surveillance systems summarized in COVIDView, including methodology and detailed descriptions of each data component, is available on the surveillance methods page.

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html

2 COVIDView Week 23, ending June 6, 2020

Key Points

o Nationally, using combined data from the three laboratory types, the percentages of laboratory specimens testing positive for SARS-CoV-2 with a molecular assay increased slightly compared to last week.

o The national increase was driven by increases in four HHS surveillance regions: Region 2 (North East), Region 4 (South East), Region 6 (South Central), and Region 10 (Pacific Northwest).

o While the number of specimens from children <18 years of age tested is low (<5% of all specimens tested in public health and commercial laboratories), the percentage testing positive for SARS-CoV-2 in this age group is higher than it is in the adult age groups.

o While the number of COVID-19 cases reported to CDC is cumulative and continues to increase, nationally the proportion of visits to outpatient providers and emergency departments (EDs) for illnesses with symptoms consistent with COVID-19 continued to decline or remain stable at low levels. Outpatient ILI visits are below baseline nationally and in all regions of the country.

o The low levels of people presenting for care with ILI and CLI may reflect low levels of COVID-19 and other respiratory illness, which could be in part a result of widespread adoption of social distancing, in addition to changes in healthcare seeking behavior.

o There has been very little influenza virus activity in recent weeks.

o The overall cumulative COVID-19 associated hospitalization rate is 89.3 per 100,000, with the highest rates in people 65 years of age and older (273.8 per 100,000) followed by people 50-64 years (136.1 per 100,000). Hospitalization rates are cumulative and will increase as the COVID-19 pandemic continues.

o Non-Hispanic American Indian or Alaska Native persons have a rate approximately 5 times that of non-Hispanic White persons, non-Hispanic Black persons have a rate approximately 4.5 times that of non-Hispanic White persons, and Hispanic or Latino persons have a rate approximately 4 times that of non-Hispanic White persons.

o Cumulative hospitalization rates for COVID-19 in adults (18-64 years) at this time are higher than cumulative end-of-season hospitalization rates for influenza over each of the past 5 influenza seasons.

o For people 65 years and older, current cumulative COVID-19 hospitalization rates are within ranges of cumulative influenza hospitalization rates observed at comparable time points* during recent influenza seasons.

o For children (0-17 years), cumulative COVID-19 hospitalization rates are much lower than cumulative influenza hospitalization rates at comparable time points* during recent influenza seasons.

o Based on death certificate data, the percentage of deaths attributed to pneumonia, influenza or COVID-19 (PIC) decreased from 12.4% during week 22 to 7.3% during week 23. This is the seventh week during which a declining percentage of deaths due to PIC has been recorded; however, the percentage remains above the epidemic threshold. The percentage may change as additional death certificates for deaths during recent weeks are processed.

*Number of weeks since 10% of specimens tested positive for SARS-CoV-2 and influenza, respectively.


U.S. Virologic Surveillance The number of specimens tested for SARS-CoV-2 using a molecular assay and reported to CDC by public health laboratories and a subset of clinical and commercial laboratories in the United States are summarized below. All laboratories are performing primary diagnostic functions; therefore, the percentage of specimens testing positive across laboratory types can be used to monitor overall trends in COVID-19 activity. As the outbreak progresses, it is possible that different types of laboratories will take on different roles, and the data interpretation may need to change. Summary of Laboratory Testing

Results Reported to CDC* Week 23

(May 31 – June 6, 2020) Cumulative since

March 1, 2020 No. of specimens tested 1,587,072 12,604,300

Public Health Laboratories 189,815 1,650,462 Clinical Laboratories 105,670 1,089,500

Commercial Laboratories 1,291,587 9,864,338 No. of positive specimens (%) 99,357 (6.3%) 1,379,860 (10.9%)

Public Health Laboratories 9,543 (5.0%) 174,716 (10.6%) Clinical Laboratories 5,593 (5.3%) 83,910 (7.7%)

Commercial Laboratories 84,221 (6.5%) 1,121,234 (11.4%)

Public Health Laboratories

* Commercial and clinical laboratory data represents select laboratories and does not capture all tests performed in the United States.


Clinical Laboratories

Commercial Laboratories

* Commercial laboratories began testing for SARS-CoV-2 in early March, but the number and geographic distribution of reporting commercial laboratories became stable enough to calculate a weekly percentage of specimens testing positive as of March 29, 2020. Additional virologic surveillance information: Surveillance Methods

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#virologic


Outpatient/Emergency Department Illness Two syndromic surveillance systems are being used to monitor trends in outpatient and emergency department visits that may be associated with COVID-19 illness. Each system monitors a slightly different syndrome, and together these systems provide a more comprehensive picture of mild to moderate COVID-19 illness than either would individually. Both systems are currently being affected by recent changes in healthcare seeking behavior, including increased use of telemedicine, compliance with recommendations to limit emergency department (ED) visits to severe illnesses, and increased practice of social distancing. These changes affect the numbers of people seeking care in the outpatient and ED settings and their reasons for doing so. ILINet The U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) provides data on visits for influenza-like illness (ILI) (fever [≥100○F] and cough and/or sore throat) to approximately 2,600 primary care providers, emergency departments and urgent care centers in all 50 states, Puerto Rico, the District of Columbia and the U.S. Virgin Islands. Mild COVID-19 illness presents with symptoms similar to ILI, so ILINet is being used to track trends of mild to moderate COVID-19 illness and allows for comparison with prior influenza seasons. Nationwide during week 23, 0.7% of patient visits reported through ILINet were due to ILI. This percentage is well below the national baseline of 2.4% and represents the eleventh week of decline after three weeks of increase beginning in early March. The percentage of visits for ILI in week 23 remains low among all age groups. Nationally, laboratory-confirmed influenza activity as reported by clinical laboratories is at levels usually seen during summer months which, along with changes in healthcare seeking behavior and the impact of social distancing, is likely contributing to the low level of ILI activity.

* Age-group specific percentages should not be compared to the national baseline.

https://www.cdc.gov/flu/weekly/#ClinicalLaboratories

https://www.cdc.gov/flu/weekly/#ClinicalLaboratories


On a regional level, the percentage of outpatient visits for ILI ranged from 0.4% to 1.1% during week 23. All ten regions are at low levels and below their region-specific baselines. Note: In response to the COVID-19 pandemic, new sites will be enrolled in ILINet throughout the summer. This will result in an increase in patient visits and the percentage of visits for ILI may change in comparison to previous weeks. During week 21, new sites were added in Regions 1, 4, and 6. While these regions remain below baseline levels for ILI, these system changes should be kept in mind when drawing conclusions from these data. Any changes in ILI due to changes in respiratory virus circulation will be highlighted in this report. ILI Activity Levels Data collected in ILINet are used to produce a measure of ILI activity for all 50 states, Puerto Rico, the District of Columbia and New York City. The mean reported percentage of visits due to ILI for the current week is compared to the mean reported during non-influenza weeks, and the activity levels correspond to the number of standard deviations below, at or above the mean. The number of jurisdictions at each activity level during week 23 and the change compared to the previous week are summarized in the table below and shown in the following maps. The decreasing percentage of visits for ILI described above are reflected in this week’s ILI activity levels.

Activity Level

Number of Jurisdictions Week 23

(Week ending June 6, 2020)

Compared to Previous Week

Very High 0 No change High 0 No change Moderate 0 -1 Low 1 No change Minimal 52 +1 Insufficient Data 1 No change

*Data collected in ILINet may disproportionally represent certain populations within a state and may not accurately depict the full picture of influenza activity for the whole state. Differences in the data presented here by CDC and independently by some state health departments likely represent differing levels of data completeness with data presented by the state likely being the more complete.

ILI Activity Level Map, Week 22, Ending May 30, 2020 ILI Activity Level Map, Week 23, Ending June 6, 2020

https://www.hhs.gov/about/agencies/iea/regional-offices/index.html

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html


National Syndromic Surveillance Program (NSSP): Emergency Department (ED) Visits NSSP is a collaboration among CDC, federal partners, local and state health departments and academic and private sector partners to collect, analyze and share electronic patient encounter data received from multiple healthcare settings. To track trends of potential COVID-19 visits, visits for COVID-19-like illness (CLI) (fever and cough or shortness of breath or difficulty breathing or presence of a coronavirus diagnosis code) and ILI to a subset of emergency departments in 47 states are being monitored. Nationwide during week 23, 1.6% of emergency department visits captured in NSSP were due to CLI and 0.6% were due to ILI. This is the eleventh week of declining or stable percentage of visits for ILI and the ninth week of declining percentage of visits for CLI. Compared to week 22, all 10 HHS regions had declining or stable percentages of visits for CLI during week 23; all 10 regions also had declining or stable percentages of visits for ILI.

Additional information about medically attended outpatient and emergency department visits for ILI and CLI: Surveillance Methods Hospitalizations The COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) conducts population-based surveillance for laboratory-confirmed COVID-19-associated hospitalizations in select counties participating in the Emerging Infections Program (EIP) and the Influenza Hospitalization Surveillance Project (IHSP).

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

2019

4020

1941

2019

4220

1943

2019

4420

1945

2019

4620

1947

2019

4820

1949

2019

5020

1951

2019

5220

2001

2020

0220

2003

2020

0420

2005

2020

0620

2007

2020

0820

2009

2020

1020

2011

2020

1220

2013

2020

1420

2015

2020

1620

2017

2020

1820

2019

2020

2020

2021

2020

2220

2023

2020

2420

2025

Perc

ent o

f Tot

al E

D Vi

sits

Week

NSSP: Percentage of Visits for Influenza-Like Illness (ILI) and COVID-19-Like Illness (CLI) to Emergency Departments

Weekly National Summary, September 29, 2019 - June 6, 2020

Percent of Visits for CLIPercent of Visits for ILI



https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#outpatient


A total of 28,987 laboratory-confirmed COVID-19-associated hospitalizations were reported by sites between March 1, 2020, and June 6, 2020. The overall cumulative hospitalization rate was 89.3 per 100,000 population. Among the 0-4 years, 5-17 years, 18-49 years, 50-64 years, and ≥ 65 years age groups, the highest rate of hospitalization is among adults aged ≥ 65 years (273.8 per 100,000), followed by adults aged 50-64 years (136.1 per 100,000) and adults aged 18-49 years (52.4 per 100,000).

Age Group Cumulative Rate per 100,000 Population Overall 89.3 0-4 years 5.6 5-17 years 3.1 18-49 years 52.4 18-29 years 27.3 30-39 years 52.5 40-49 years 84.6

50-64 years 136.1 65+ years 273.8 65-74 years 198.7 75-84 years 329.3

85+ years 513.2


Among the 28,987 laboratory-confirmed COVID-19-associated hospitalized cases, 24,936 (86.0%) had information on race and ethnicity, while collection of race and ethnicity was still pending for 4,051 (14.0%) cases. Of the 24,936 cases with race and ethnicity data, 34.2% were non-Hispanic White, 32.9% were non-Hispanic Black, 20.2% were Hispanic or Latino, 4.6% were non-Hispanic Asian or Pacific Islander, and 1.5% were non-Hispanic American Indian or Alaska Native persons. Persons of multiple races represented 0.2% of cases, and 6.4% of cases had unknown race and ethnicity. In comparison, the COVID-NET catchment area population includes 58.8% non-Hispanic White, 17.7% non-Hispanic Black, 14.0% Hispanic or Latino, 8.8% non-Hispanic Asian or Pacific Islander, and 0.7% non-Hispanic American Indian or Alaska Native residents. Additional data on race and ethnicity are available. COVID-19-associated hospitalization rates by race/ethnicity are calculated using hospitalized COVID-NET cases with known race and ethnicity for the numerator and NCHS bridged-race population estimates (https://www.cdc.gov/nchs/nvss/bridged_race.htm) for the denominator. Rates are adjusted to account for differences in age distributions within race/ethnicity strata in the COVID-NET catchment area; the age strata used for the adjustment include 0-17, 18-49, 50-64, 65-74, 75-84, and ≥ 85 years. Age-adjusted hospitalization rates are highest among non-Hispanic American Indian or Alaska Native and non-Hispanic Black persons, followed by Hispanic or Latino persons. Non-Hispanic American Indian or Alaska Native persons have a rate approximately 5 times that of non-Hispanic White persons, non-Hispanic Black persons have a rate approximately 4.5 times that of non-Hispanic White persons, while Hispanic or Latino persons have a rate approximately 4 times that of non-Hispanic White persons.

193.8171.8

150.3

44.9 37.8

0

50

100

150

200

250

Non-HispanicAmerican Indian or

Alaska Native

Non-Hispanic Black Hispanic or Latino Non-HispanicAsian or Pacific

Islander

Non-HispanicWhite

Rate

per

100

,000

pop

ulat

ion

Race and Ethnicity

Age-adjusted COVID-19-associated hospitalization rates by race and ethnicity — COVID-NET, March 1–June 6, 2020

https://gis.cdc.gov/grasp/COVIDNet/COVID19_5.html

https://www.cdc.gov/nchs/nvss/bridged_race.htm


Among 6,693 hospitalized adults with information on underlying medical conditions, 91.5% had at least one reported underlying medical condition. The most commonly reported were hypertension, obesity, chronic metabolic disease, and cardiovascular disease. Among 128 hospitalized children with information on underlying conditions, 53.1% had at least one reported underlying medical condition. The most commonly reported condition was obesity.

Additional data on demographics, signs and symptoms at admission, underlying conditions, interventions, outcomes, and discharge diagnoses, stratified by age, sex, and race and ethnicity, are available. Additional hospitalization surveillance information: Surveillance Methods | Additional rate data | Additional demographic and clinical data


https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#hospitalization




Mortality Surveillance The National Center for Health Statistics (NCHS) collects death certificate data from vital statistics offices for all deaths occurring in the United States. Based on death certificate data available on June 11, 2020, 7.3% of all deaths occurring during the week ending June 6, 2020 (week 23) were due to pneumonia, influenza or COVID-19 (PIC). This is the seventh week of a declining percentage of deaths due to PIC; however, the percentage remains above the epidemic threshold of 6.2% for week 23. Data for recent weeks are incomplete, and the PIC percentage may increase as more death certificates representing deaths during these weeks are processed. Weekly mortality surveillance data include a combination of machine coded and manually coded causes of death collected from death certificates. Percentages of deaths due to PIC are higher among manually coded records than more rapidly available machine coded records. Due to the additional time needed for manual coding, the initially reported PIC percentages may be lower than percentages calculated from final data.

*Data during recent weeks are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes.

Additional NCHS mortality surveillance information: Surveillance Methods | Provisional Death Counts for COVID-19 Report prepared: June 11, 2020

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/purpose-methods.html#mortality

https://www.cdc.gov/nchs/nvss/vsrr/COVID19/index.htm

https://www.cdc.gov/nchs/nvss/vsrr/COVID19/index.htm


U.S. State and Local Public Health Laboratories Reporting to CDC March 1, 2020 – June 6, 2020

Data as of June 11, 2020

National

Week

No. of Labs

Total (includes age unknown) 0-4 years 5-17 years 18-49 years 50-64 years 65+ years

Spec Tested # Pos % Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Test-ed # Pos

% Pos

Spec Tested # Pos

% Pos

Spec Tested # Pos

% Pos

202010 77 8,123 973 12.0 223 10 4.5 582 42 7.2 3,144 318 10.1 1,931 247 12.8 2,095 330 15.8

202011 85 35,285 3,477 9.9 965 20 2.1 1,953 83 4.2 15,371 1,369 8.9 8,291 983 11.9 7,828 942 12.0

202012 87 69,257 6,795 9.8 1,557 35 2.2 2,312 86 3.7 31,617 2,643 8.4 16,011 1,806 11.3 16,203 2,083 12.9

202013 89 65,829 10,687 16.2 1,248 47 3.8 1,419 79 5.6 29,529 3,781 12.8 15,424 2,897 18.8 17,501 3,754 21.5

202014 89 78,599 13,918 17.7 1,118 63 5.6 1,448 169 11.7 34,435 4,465 13.0 18,647 3,593 19.3 22,406 5,533 24.7

202015 88 82,690 15,049 18.2 908 43 4.7 1,609 168 10.4 34,837 4,402 12.6 19,882 3,629 18.3 25,015 6,722 26.9

202016 86 83,661 15,201 18.2 776 62 8.0 1,465 146 10.0 36,085 5,257 14.6 19,040 3,322 17.4 25,901 6,341 24.5

202017 85 129,621 21,280 16.4 893 54 6.0 2,517 332 13.2 58,949 8,596 14.6 29,112 4,701 16.1 37,392 7,454 19.9

202018 86 150,078 19,296 12.9 1,183 108 9.1 3,917 468 11.9 65,873 8,013 12.2 34,386 4,110 12.0 44,087 6,527 14.8

202019 85 162,808 17,419 10.7 1,708 100 5.9 4,349 512 11.8 71,947 7,679 10.7 37,892 3,560 9.4 46,280 5,484 11.8

202020 86 178,851 15,001 8.4 1,365 103 7.5 5,022 503 10.0 77,348 6,856 8.9 40,771 2,901 7.1 53,833 4,574 8.5 202021 84 208,856 14,138 6.8 1,715 126 7.3 6,040 625 10.3 93,067 6,587 7.1 46,193 2,708 5.9 61,191 4,035 6.6 202022 84 206,989 11,939 5.8 1,450 140 9.7 5,686 594 10.4 92,130 5,598 6.1 45,960 2,289 5.0 61,327 3,308 5.4 202023 79 189,815 9,543 5.0 1,433 129 9.0 5,467 572 10.5 86,562 4,800 5.5 41,566 1,696 4.1 54,290 2,332 4.3

Total . 1,650,462 174,716 10.6 16,542 1,040 6.3 43,786 4,379 10.0 730,894 70,364 9.6 375,106 38,442 10.2 475,349 59,419 12.5

Region 1 (CT, ME, MA, NH, RI, VT)

Week No. of Labs


202010 8 716 142 19.83 202011 17 3308 283 8.56 202012 18 9617 732 7.61 202013 16 4635 701 15.12 202014 15 6169 1623 26.31 202015 18 8244 2424 29.40 202016 13 11653 2650 22.74 202017 12 17153 2983 17.39 202018 12 11281 1813 16.07 202019 11 10037 1623 16.17 202020 11 11380 1118 9.82 202021 18 14227 1074 7.55 202022 17 14728 802 5.45 202023 15 12986 633 4.87

Total 136134 18601 13.66


Region 2 (NJ, NY, PR)

Week No. of Labs


202010 6 1435 193 13.45 202011 21 5421 788 14.54 202012 26 10498 1443 13.75 202013 21 6776 2250 33.21 202014 24 7056 2288 32.43 202015 19 6413 1707 26.62 202016 19 5077 1243 24.48 202017 18 5816 1051 18.07 202018 18 7560 954 12.62 202019 16 10665 874 8.20 202020 14 14892 684 4.59 202021 14 8918 360 4.04 202022 18 8858 282 3.18 202023 15 6818 165 2.42

Total 106203 14282 13.45

Region 3 (DE, DC, MD, PA, VA, WV)

Week No. of Labs


202010 8 334 30 8.98 202011 22 1651 250 15.14 202012 22 2686 377 14.04 202013 19 4145 783 18.89 202014 18 5559 1348 24.25 202015 20 5339 1835 34.37 202016 21 4975 1839 36.96 202017 16 6151 2079 33.80 202018 17 7062 1664 23.56 202019 20 5806 1293 22.27 202020 16 8738 1484 16.98 202021 22 9193 1211 13.17 202022 26 9545 1005 10.53 202023 21 10495 740 7.05

Total 81679 15938 19.51


Region 4 (AL, FL, GA, KY, MS, NC, SC, TN)

Week No. of Labs


202010 17 759 69 9.09 202011 29 4483 449 10.02 202012 38 10842 1000 9.22 202013 31 12571 1723 13.71 202014 32 14925 2121 14.21 202015 31 17887 2658 14.86 202016 30 14105 2188 15.51 202017 26 17567 2624 14.94 202018 25 18606 2608 14.02 202019 30 21349 2295 10.75 202020 30 23617 2371 10.04 202021 33 31057 2168 6.98 202022 30 40603 2432 5.99 202023 30 31697 2114 6.67

Total 260068 26820 10.31

Region 5 (IL, IN, MI, MN, OH, WI)

Week No. of Labs


202010 18 761 35 4.60 202011 28 7071 492 6.96 202012 31 12255 1227 10.01 202013 27 12146 2654 21.85 202014 29 14477 3067 21.19 202015 29 14278 2772 19.41 202016 24 12078 2211 18.31 202017 23 23308 5099 21.88 202018 22 39305 6094 15.50 202019 23 33565 4660 13.88 202020 28 36345 3376 9.29 202021 26 37424 3105 8.30 202022 31 33341 1968 5.90 202023 25 38369 1490 3.88

Total 314723 38250 12.15


Region 6 (AR, LA, NM, OK, TX)

Week No. of Labs


202010 9 282 11 3.90 202011 23 2768 329 11.89 202012 31 4496 863 19.19 202013 30 4778 850 17.79 202014 28 5990 1005 16.78 202015 24 5638 911 16.16 202016 26 4269 896 20.99 202017 23 11227 1044 9.30 202018 23 13867 1150 8.29 202019 21 19478 1291 6.63 202020 26 19566 1599 8.17 202021 27 27974 1598 5.71 202022 26 21573 1274 5.91 202023 21 13862 938 6.77

Total 155768 13759 8.83

Region 7 (IA, KS, MO, NE)

Week No. of Labs


202010 7 268 43 16.04 202011 16 1113 70 6.29 202012 18 2920 148 5.07 202013 12 3665 330 9.00 202014 14 4547 513 11.28 202015 11 5746 704 12.25 202016 12 7683 1678 21.84 202017 12 15104 3787 25.07 202018 10 10709 2223 20.76 202019 20 13780 2399 17.41 202020 18 11253 1891 16.80 202021 17 11621 1652 14.22 202022 16 11340 1283 11.31 202023 13 10362 908 8.76

Total 110111 17629 16.0102


Region 8 (CO, MT, ND, SD, UT, WY)

Week No. of Labs


202010 7 565 28 4.96 202011 15 4234 347 8.20 202012 14 7644 353 4.62 202013 16 7546 390 5.17 202014 13 8750 613 7.01 202015 13 7826 451 5.76 202016 14 9589 746 7.78 202017 14 16537 1068 6.46 202018 16 22760 798 3.51 202019 18 21874 816 3.73 202020 16 26903 922 3.43 202021 19 35784 1361 3.80 202022 18 33123 1162 3.51 202023 15 35524 928 2.61

Total 238659 9983 4.18

Region 9 (AZ, CA, GU, HI, NV)

Week No. of Labs


202010 26 1422 150 10.55 202011 40 3549 373 10.51 202012 48 5178 403 7.78 202013 45 6398 706 11.03 202014 43 7436 1000 13.45 202015 41 8082 1368 16.93 202016 36 9192 1458 15.86 202017 36 12215 1325 10.85 202018 33 14457 1661 11.49 202019 36 20535 1858 9.05 202020 40 20290 1307 6.44 202021 37 25020 1288 5.15 202022 41 26609 1294 4.86 202023 41 24678 1139 4.62

Total 185061 15330 8.28


Region 10 (AK, ID, OR, WA)

Week No. of Labs


202010 8 1581 272 17.20 202011 19 1687 96 5.69 202012 14 3121 249 7.98 202013 15 3169 300 9.47 202014 15 3690 340 9.21 202015 10 3237 219 6.77 202016 12 5040 292 5.79 202017 12 4543 220 4.84 202018 13 4471 331 7.40 202019 14 5719 310 5.42 202020 12 5867 249 4.24 202021 14 7638 321 4.20 202022 14 7269 437 6.01 202023 20 5024 488 9.71

Total 62056 4124 6.65


U.S. Clinical Laboratories Reporting SARS-CoV-2 Test Results to CDC March 8, 2020 - June 6, 2020


National

Week Number of Labs Reporting Spec Tested # Pos % Pos

202011 28 2,493 147 5.9 202012 45 18,759 1,169 6.2 202013 56 45,031 3,957 8.8 202014 67 55,919 6,250 11.2 202015 85 56,303 7,107 12.6 202016 101 67,370 7,391 11.0 202017 109 87,926 9,189 10.5 202018 116 108,883 9,849 9.1 202019 123 127,763 8,976 7.0 202020 118 137,638 8,802 6.4 202021 116 139,651 8,065 5.8 202022 121 136,094 7,415 5.5 202023 71 105,670 5,593 5.3

Total 160 1,089,500 83,910 7.7


U.S. Commercial Laboratories Reporting to CDC March 29, 2020 – June 6, 2020

Data as of June 11, 2020 National

Week No. of

Labs

Total (includes age unknown) 0-4 years 5-17 years 18-49 years 50-64 years 65+ years Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos % Pos Spec


Tested # Pos % Pos 202014 6 542,234 125,169 23.1 8,390 533 6.4 13,565 1,866 13.8 289,492 61,085 21.1 130,456 35,086 26.9 76,179 20,996 27.6

202015 6 501,137 114,336 22.8 6,810 601 8.8 12,926 2,153 16.7 259,055 55,337 21.4 124,547 31,675 25.4 73,455 19,213 26.2

202016 6 508,711 98,704 19.4 6,406 580 9.1 15,156 2,360 15.6 242,816 46,182 19.0 122,695 24,903 20.3 79,090 16,154 20.4

202017 6 615,041 97,488 15.9 7,795 686 8.8 19,756 2,993 15.1 296,284 48,647 16.4 152,522 24,066 15.8 110,234 16,806 15.2

202018 6 742,413 96,066 12.9 9,884 834 8.4 24,641 3,623 14.7 352,758 49,216 14.0 181,782 22,287 12.3 138,056 15,949 11.6

202019 6 872,468 85,988 9.9 12,207 951 7.8 30,185 3,846 12.7 401,318 44,701 11.1 212,029 18,817 8.9 174,790 13,793 7.9

202020 6 1,093,319 83,610 7.6 15,565 1,151 7.4 38,688 4,294 11.1 494,079 43,761 8.9 264,430 17,406 6.6 228,438 13,211 5.8

202021 6 1,322,256 86,510 6.5 17,204 1,302 7.6 44,509 4,758 10.7 616,428 46,619 7.6 314,920 17,275 5.5 263,869 12,480 4.7

202022 6 1,300,419 79,257 6.1 15,518 1,112 7.2 42,445 4,616 10.9 608,372 43,416 7.1 310,682 15,883 5.1 254,987 10,575 4.1

202023 6 1,291,587 84,221 6.5 13,977 1,164 8.3 39,055 4,559 11.7 537,219 39,624 7.4 264,682 14,629 5.5 223,510 9,369 4.2

Total

8,789,585 951,349 10.8 113,756 8,914 7.8 280,926 35,068 12.5 4,097,821 478,588 11.7 2,078,745 222,027 10.7 1,622,608 148,546 9.2


Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec



Tested # Pos %

Pos 202014 6 42,062 10,442 24.8 474 34 7.2 825 157 19.0 21,467 4,902 22.8 10,982 2,950 26.9 6,582 1,986 30.2

202015 6 41,142 10,589 25.7 450 43 9.6 926 182 19.7 20,085 4,847 24.1 11,106 2,909 26.2 6,659 2,104 31.6

202016 6 41,038 10,332 25.2 424 74 17.5 1,111 229 20.6 17,814 4,323 24.3 9,593 2,320 24.2 6,385 1,872 29.3

202017 5 51,328 10,425 20.3 559 98 17.5 1,628 333 20.5 24,845 4,994 20.1 13,174 2,450 18.6 8,926 2,099 23.5

202018 6 64,874 10,547 16.3 670 93 13.9 1,923 389 20.2 31,688 5,027 15.9 16,242 2,375 14.6 11,716 2,265 19.3

202019 6 68,825 9,481 13.8 733 100 13.6 2,115 398 18.8 31,583 4,477 14.2 17,142 2,098 12.2 14,434 2,058 14.3

202020 6 91,202 8,414 9.2 1,024 104 10.2 2,742 356 13.0 40,531 3,928 9.7 23,723 1,847 7.8 19,222 1,833 9.5

202021 6 84,795 7,298 8.6 1,133 123 10.9 2,703 346 12.8 37,698 3,350 8.9 21,028 1,506 7.2 18,735 1,699 9.1

202022 6 73,793 4,791 6.5 889 74 8.3 2,237 267 11.9 33,241 2,191 6.6 17,994 1,054 5.9 16,476 1,014 6.2

202023 6 77,338 4,512 5.8 759 69 9.1 2,219 253 11.4 30,599 2,000 6.5 17,268 919 5.3 15,040 755 5.0

Total

636,397 86,831 13.6 7,115 812 11.4 18,429 2,910 15.8 289,551 40,039 13.8 158,252 20,428 12.9 124,175 17,685 14.2


Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec



Tested # Pos %

Pos 202014 6 135,028 66,753 49.4 1,439 332 23.1 3,143 1,117 35.5 71,270 32,711 45.9 35,743 18,960 53.0 17,681 10,760 60.9

202015 6 142,565 62,919 44.1 1,435 355 24.7 3,882 1,310 33.7 74,316 30,508 41.1 38,882 18,151 46.7 17,873 9,840 55.1

202016 6 133,882 47,070 35.2 1,262 239 18.9 4,450 1,218 27.4 66,494 21,982 33.1 35,697 12,950 36.3 17,065 7,275 42.6

202017 6 144,033 39,254 27.3 1,241 149 12.0 4,718 1,145 24.3 70,102 18,597 26.5 39,082 10,716 27.4 22,391 6,920 30.9

202018 6 155,377 30,835 19.8 1,456 172 11.8 5,304 1,043 19.7 74,022 14,863 20.1 41,794 8,086 19.3 25,933 5,301 20.4

202019 6 160,730 22,113 13.8 1,438 149 10.4 5,455 789 14.5 74,051 10,280 13.9 42,989 5,636 13.1 29,808 4,297 14.4

202020 6 208,162 19,105 9.2 1,865 132 7.1 7,602 761 10.0 95,234 8,959 9.4 54,860 4,721 8.6 39,428 3,735 9.5

202021 6 346,218 16,735 4.8 2,332 113 4.8 8,702 553 6.4 162,794 7,725 4.7 93,318 4,184 4.5 59,461 3,382 5.7

202022 6 383,313 14,808 3.9 2,088 72 3.4 7,570 591 7.8 183,390 6,955 3.8 105,393 3,763 3.6 61,184 2,696 4.4

202023 6 336,753 19,368 5.8 1,788 115 6.4 6,696 829 12.4 135,268 7,170 5.3 80,145 4,192 5.2 51,198 2,808 5.5

Total

2,146,061 338,960 15.8 16,344 1,828 11.2 57,522 9,356 16.3 1,006,941 159,750 15.9 567,903 91,359 16.1 342,022 57,014 16.7



Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec



Tested # Pos %

Pos 202014 6 56,110 10,631 18.9 932 33 3.5 1,289 147 11.4 30,604 5,419 17.7 13,657 3,003 22.0 7,316 1,582 21.6

202015 6 50,813 10,869 21.4 757 48 6.3 1,132 179 15.8 26,651 5,399 20.3 12,626 2,925 23.2 7,308 1,798 24.6

202016 6 50,957 11,520 22.6 704 79 11.2 1,186 209 17.6 24,568 5,557 22.6 11,563 2,636 22.8 7,642 1,938 25.4

202017 6 77,640 12,712 16.4 916 124 13.5 1,726 394 22.8 38,085 6,654 17.5 18,429 2,837 15.4 15,294 2,218 14.5

202018 6 82,403 14,272 17.3 1,117 180 16.1 2,364 528 22.3 42,146 7,798 18.5 18,942 2,991 15.8 14,154 2,208 15.6

202019 6 92,653 13,487 14.6 1,378 227 16.5 2,838 653 23.0 46,934 7,659 16.3 21,945 2,638 12.0 15,619 1,745 11.2

202020 6 117,865 13,567 11.5 1,737 240 13.8 3,691 702 19.0 56,179 7,748 13.8 27,988 2,549 9.1 23,184 1,752 7.6

202021 6 141,975 14,054 9.9 1,870 231 12.4 4,732 838 17.7 71,417 8,195 11.5 31,993 2,566 8.0 25,601 1,516 5.9

202022 6 137,419 11,020 8.0 1,697 161 9.5 4,338 665 15.3 66,687 6,328 9.5 30,768 2,029 6.6 26,437 1,347 5.1

202023 6 141,947 9,197 6.5 1,436 133 9.3 3,944 478 12.1 60,040 4,340 7.2 26,717 1,461 5.5 23,196 870 3.8

Total

949,782 121,329 12.8 12,544 1,456 11.6 27,240 4,793 17.6 463,311 65,097 14.1 214,628 25,635 11.9 165,751 16,974 10.2


Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos % Pos 202014 6 94,666 10,249 10.8 1,459 35 2.4 2,185 96 4.4 49,614 4,819 9.7 22,506 2,831 12.6 14,671 1,976 13.5

202015 6 80,496 8,164 10.1 936 38 4.1 1,708 107 6.3 40,136 3,885 9.7 19,704 2,168 11.0 13,439 1,485 11.0

202016 6 98,374 8,718 8.9 1,120 41 3.7 2,674 224 8.4 43,439 4,126 9.5 25,030 2,085 8.3 18,650 1,472 7.9

202017 6 109,675 8,988 8.2 1,371 70 5.1 3,245 232 7.1 48,604 4,522 9.3 28,181 2,156 7.7 23,406 1,639 7.0

202018 6 133,217 9,573 7.2 1,667 81 4.9 3,847 359 9.3 57,634 4,933 8.6 34,266 2,134 6.2 30,032 1,686 5.6

202019 6 159,164 9,182 5.8 1,921 70 3.6 4,553 372 8.2 66,615 4,949 7.4 39,962 1,973 4.9 39,011 1,413 3.6

202020 6 204,689 10,702 5.2 2,758 155 5.6 6,274 645 10.3 83,576 5,532 6.6 49,773 2,036 4.1 53,382 1,910 3.6

202021 6 232,473 13,999 6.0 3,266 246 7.5 8,114 838 10.3 100,088 7,680 7.7 54,896 2,631 4.8 56,091 2,035 3.6

202022 6 199,289 14,210 7.1 2,954 210 7.1 7,532 917 12.2 88,663 7,918 8.9 46,439 2,624 5.7 44,686 1,907 4.3

202023 6 226,284 16,424 7.3 2,942 299 10.2 7,719 959 12.4 91,338 8,245 9.0 47,268 2,633 5.6 45,981 1,928 4.2

Total

1,538,327 110,209 7.2 20,394 1,245 6.1 47,851 4,749 9.9 669,707 56,609 8.5 368,025 23,271 6.3 339,349 17,451 5.1


Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos 202014 6 42,224 7,823 18.5 671 9 1.3 792 50 6.3 22,166 3,649 16.5 10,139 2,220 21.9 6,679 1,513 22.7

202015 6 35,613 5,934 16.7 555 7 1.3 652 40 6.1 18,076 2,857 15.8 8,851 1,658 18.7 5,920 1,087 18.4

202016 6 34,017 5,242 15.4 517 28 5.4 735 66 9.0 16,287 2,333 14.3 8,039 1,350 16.8 5,816 1,021 17.6

202017 6 50,466 7,081 14.0 726 39 5.4 1,310 181 13.8 25,138 3,687 14.7 12,645 1,691 13.4 8,613 1,228 14.3

202018 6 71,336 9,994 14.0 1,064 71 6.7 2,000 311 15.6 35,298 5,386 15.3 17,449 2,263 13.0 12,349 1,542 12.5

202019 6 117,151 10,683 9.1 1,703 129 7.6 3,515 499 14.2 55,201 5,856 10.6 29,438 2,258 7.7 21,789 1,463 6.7

202020 6 140,772 10,751 7.6 2,037 150 7.4 4,637 534 11.5 65,228 5,975 9.2 34,141 2,187 6.4 28,214 1,483 5.3

202021 6 149,585 11,471 7.7 2,061 180 8.7 4,790 588 12.3 71,580 6,741 9.4 34,646 2,189 6.3 29,787 1,308 4.4

202022 6 146,292 8,729 6.0 1,824 105 5.8 4,804 469 9.8 68,477 4,974 7.3 33,183 1,677 5.1 30,953 1,139 3.7

202023 6 160,702 8,549 5.3 1,749 100 5.7 4,537 392 8.6 71,056 4,261 6.0 29,604 1,386 4.7 28,764 905 3.1

Total

948,158 86,257 9.1 12,907 818 6.3 27,772 3,130 11.3 448,507 45,719 10.2 218,135 18,879 8.7 178,884 12,689 7.1



Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos 202014 6 63,023 8,588 13.6 1,351 43 3.2 1,992 130 6.5 35,174 4,369 12.4 13,435 2,298 17.1 7,295 1,190 16.3

202015 6 56,639 6,585 11.6 1,113 54 4.9 1,791 165 9.2 30,814 3,373 10.9 12,114 1,630 13.5 7,014 946 13.5

202016 6 63,367 6,593 10.4 1,045 63 6.0 2,143 194 9.1 32,186 3,506 10.9 13,815 1,488 10.8 8,938 825 9.2

202017 6 74,458 7,477 10.0 1,283 89 6.9 3,013 303 10.1 37,659 4,181 11.1 16,305 1,607 9.9 11,134 784 7.0

202018 6 90,819 7,700 8.5 1,630 106 6.5 3,641 388 10.7 43,956 4,291 9.8 19,903 1,584 8.0 14,911 858 5.8

202019 6 102,510 8,024 7.8 2,003 116 5.8 4,112 360 8.8 47,931 4,614 9.6 22,071 1,612 7.3 18,544 834 4.5

202020 6 118,680 8,077 6.8 2,420 151 6.2 5,066 490 9.7 54,938 4,574 8.3 25,321 1,521 6.0 22,091 790 3.6

202021 6 153,162 9,264 6.0 2,894 166 5.7 6,139 628 10.2 72,359 5,283 7.3 32,114 1,685 5.2 30,148 940 3.1

202022 6 130,406 8,948 6.9 2,517 216 8.6 5,772 662 11.5 59,175 5,133 8.7 27,291 1,563 5.7 27,732 862 3.1

202023 6 111,899 9,729 8.7 2,012 183 9.1 5,049 644 12.8 44,953 4,871 10.8 18,577 1,313 7.1 16,539 683 4.1

Total

964,963 80,985 8.4 18,268 1,187 6.5 38,718 3,964 10.2 459,145 44,195 9.6 200,946 16,301 8.1 164,346 8,712 5.3


Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos 202014 6 12,561 1,389 11.1 292 6 2.1 358 17 4.7 6,702 634 9.5 2,955 436 14.8 1,732 239 13.8

202015 5 10,477 1,032 9.9 198 2 1.0 310 12 3.9 5,549 546 9.8 2,461 293 11.9 1,495 145 9.7

202016 6 11,197 1,527 13.6 212 4 1.9 290 26 9.0 5,452 783 14.4 2,332 344 14.8 1,515 206 13.6

202017 5 16,460 3,046 18.5 314 31 9.9 638 106 16.6 8,730 1,715 19.6 3,727 768 20.6 2,350 304 12.9

202018 6 24,983 3,301 13.2 429 38 8.9 995 174 17.5 12,271 1,891 15.4 5,935 767 12.9 4,149 292 7.0

202019 6 27,505 2,403 8.7 493 31 6.3 1,071 117 10.9 13,058 1,360 10.4 6,257 481 7.7 5,165 282 5.5

202020 6 34,053 2,166 6.4 657 32 4.9 1,262 131 10.4 15,531 1,256 8.1 8,133 427 5.3 6,919 232 3.4

202021 6 32,485 2,172 6.7 653 45 6.9 1,366 153 11.2 14,872 1,253 8.4 7,006 343 4.9 7,179 272 3.8

202022 6 36,424 1,795 4.9 600 42 7.0 1,380 150 10.9 15,021 1,013 6.7 8,492 310 3.7 9,333 195 2.1

202023 6 37,445 1,357 3.6 570 25 4.4 1,149 66 5.7 13,884 665 4.8 7,414 196 2.6 7,974 135 1.7

Total

243,590 20,188 8.3 4,418 256 5.8 8,819 952 10.8 111,070 11,116 10.0 54,712 4,365 8.0 47,811 2,302 4.8


Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos 202014 6 20,196 1,987 9.8 502 14 2.8 856 34 4.0 12,243 1,135 9.3 3,697 449 12.1 2,086 280 13.4

202015 6 12,920 1,510 11.7 290 9 3.1 501 30 6.0 7,225 803 11.1 2,464 340 13.8 1,831 270 14.7

202016 6 11,046 1,021 9.2 194 8 4.1 481 15 3.1 5,781 533 9.2 2,149 201 9.4 1,374 111 8.1

202017 6 13,784 1,378 10.0 272 14 5.1 666 53 8.0 7,341 809 11.0 2,986 288 9.6 1,799 123 6.8

202018 6 15,790 1,460 9.2 352 17 4.8 847 68 8.0 8,060 822 10.2 3,288 281 8.5 2,371 193 8.1

202019 6 23,141 2,198 9.5 520 28 5.4 1,635 184 11.3 11,687 1,246 10.7 4,577 409 8.9 3,524 185 5.2

202020 6 22,467 1,667 7.4 512 22 4.3 1,177 96 8.2 10,956 919 8.4 4,568 287 6.3 3,849 155 4.0

202021 6 25,463 1,436 5.6 497 19 3.8 1,246 90 7.2 12,059 816 6.8 5,234 235 4.5 4,854 108 2.2

202022 6 27,407 918 3.3 467 17 3.6 1,502 60 4.0 12,645 544 4.3 5,458 169 3.1 5,888 78 1.3

202023 6 26,187 1,053 4.0 394 14 3.6 1,101 68 6.2 12,519 623 5.0 4,383 164 3.7 4,653 72 1.5

Total

198,401 14,628 7.4 4,000 162 4.1 10,012 698 7.0 100,516 8,250 8.2 38,804 2,823 7.3 32,229 1,575 4.9



Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos 202014 6 56,904 5,942 10.4 865 22 2.5 1,479 87 5.9 29,352 2,742 9.3 12,998 1,576 12.1 9,719 1,271 13.1

202015 6 52,748 5,494 10.4 774 38 4.9 1,498 102 6.8 26,584 2,494 9.4 12,279 1,294 10.5 9,411 1,333 14.2

202016 6 51,913 5,679 10.9 693 40 5.8 1,619 139 8.6 24,115 2,536 10.5 11,588 1,276 11.0 9,773 1,286 13.2

202017 6 62,673 6,088 9.7 865 64 7.4 2,332 224 9.6 28,298 2,893 10.2 14,722 1,310 8.9 13,872 1,362 9.8

202018 6 89,129 7,395 8.3 1,226 68 5.5 3,161 307 9.7 40,394 3,618 9.0 20,799 1,629 7.8 19,832 1,483 7.5

202019 6 104,896 7,497 7.1 1,727 88 5.1 4,309 428 9.9 46,436 3,718 8.0 24,164 1,525 6.3 23,825 1,417 5.9

202020 6 137,670 8,214 6.0 2,138 142 6.6 5,519 512 9.3 63,547 4,321 6.8 31,966 1,645 5.1 28,618 1,236 4.3

202021 6 138,996 9,146 6.6 2,136 156 7.3 5,978 658 11.0 65,587 5,003 7.6 30,937 1,767 5.7 28,452 1,151 4.0

202022 6 150,491 13,173 8.8 2,201 199 9.0 6,629 782 11.8 73,942 7,858 10.6 32,305 2,522 7.8 28,821 1,248 4.3

202023 6 154,162 12,967 8.4 2,009 211 10.5 5,875 792 13.5 69,199 6,822 9.9 29,541 2,195 7.4 26,732 1,147 4.3

Total

999,582 81,595 8.2 14,634 1,028 7.0 38,399 4,031 10.5 467,454 42,005 9.0 221,299 16,739 7.6 199,055 12,934 6.5


Week No. of

Labs


Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos Spec

Tested # Pos %

Pos 202014 6 19,335 1,365 7.1 404 5 1.2 646 31 4.8 10,824 705 6.5 4,303 363 8.4 2,413 199 8.2

202015 6 17,709 1,240 7.0 302 7 2.3 525 26 5.0 9,613 625 6.5 4,054 307 7.6 2,504 205 8.2

202016 6 12,906 1,002 7.8 235 4 1.7 466 40 8.6 6,672 503 7.5 2,886 253 8.8 1,931 148 7.7

202017 6 14,434 1,039 7.2 246 8 3.3 476 22 4.6 7,455 595 8.0 3,249 243 7.5 2,421 129 5.3

202018 6 14,419 988 6.9 273 8 2.9 558 56 10.0 7,258 586 8.1 3,152 177 5.6 2,590 121 4.7

202019 6 15,843 920 5.8 290 13 4.5 582 46 7.9 7,794 542 7.0 3,472 187 5.4 3,065 99 3.2

202020 6 17,731 947 5.3 417 23 5.5 717 67 9.3 8,343 549 6.6 3,953 186 4.7 3,528 85 2.4

202021 6 17,082 935 5.5 362 23 6.4 739 66 8.9 7,964 573 7.2 3,744 169 4.5 3,556 69 1.9

202022 6 15,527 865 5.6 281 16 5.7 681 53 7.8 7,115 502 7.1 3,341 172 5.1 3,457 89 2.6

202023 6 18,781 1,064 5.7 316 15 4.7 745 77 10.3 8,331 627 7.5 3,750 170 4.5 3,424 66 1.9

Total

163,767 10,365 6.3 3,126 122 3.9 6,135 484 7.9 81,369 5,807 7.1 35,904 2,227 6.2 28,889 1,210 4.2


U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet): Overall Percentage of Visits for ILI September 29, 2019 – June 6, 2020


National (Baseline: 2.4%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 2,911 6,219 7,658 4,828 1,764 1,449 21,918 1,458,042 1.5 1.5 201941 2,942 6,552 7,637 5,150 2,015 1,604 22,958 1,436,493 1.6 1.6 201942 2,966 7,289 8,296 5,549 2,111 1,651 24,896 1,430,698 1.7 1.7 201943 2,997 7,893 9,354 6,082 2,305 1,794 27,428 1,473,576 1.9 1.8 201944 3,006 8,660 10,076 6,145 2,279 1,764 28,924 1,435,769 2.0 2.0 201945 3,021 10,559 12,555 7,180 2,453 1,843 34,590 1,462,807 2.4 2.4 201946 2,989 11,448 13,676 7,909 2,740 1,970 37,743 1,426,570 2.6 2.6 201947 2,985 12,716 17,056 9,138 3,100 2,148 44,158 1,484,729 3.0 2.9 201948 2,993 14,446 14,821 9,209 3,199 2,372 44,047 1,275,480 3.5 3.4 201949 2,995 13,857 16,400 11,948 3,929 2,780 48,914 1,476,092 3.3 3.3 201950 2,957 14,732 21,883 12,824 4,115 2,905 56,459 1,458,418 3.9 3.9 201951 2,925 18,005 29,186 16,232 4,835 3,349 71,607 1,424,103 5.0 5.1 201952 2,916 24,101 34,003 24,618 7,637 5,407 95,766 1,338,744 7.2 7.1 202001 2,965 21,627 23,413 27,646 9,207 6,876 88,769 1,425,341 6.2 5.9 202002 2,996 15,568 22,747 23,632 8,196 5,466 75,609 1,488,319 5.1 5.0 202003 2,986 16,552 29,638 21,401 7,374 4,730 79,695 1,484,113 5.4 5.4 202004 2,988 18,579 35,270 23,639 7,965 4,668 90,121 1,493,443 6.0 6.1 202005 2,985 20,301 44,101 28,875 9,517 5,477 108,271 1,572,454 6.9 6.8 202006 2,994 20,259 45,524 29,831 10,045 5,697 111,356 1,567,859 7.1 6.8 202007 2,957 17,389 36,891 26,425 9,215 5,452 95,372 1,530,084 6.2 6.1 202008 2,972 15,331 28,531 23,191 8,316 5,184 80,553 1,429,921 5.6 5.6 202009 2,930 13,779 25,433 22,102 8,260 5,106 74,680 1,459,359 5.1 5.2 202010 2,898 13,884 26,386 23,897 8,884 5,700 78,751 1,484,276 5.3 5.3 202011 2,823 14,105 27,702 29,632 11,313 6,693 89,445 1,416,898 6.3 5.7 202012 2,783 10,743 17,477 30,773 12,461 6,977 78,431 1,063,891 7.4 6.4 202013 2,708 5,105 8,283 22,374 10,814 6,450 53,026 848,798 6.2 4.9 202014 2,661 2,354 4,839 14,894 8,673 5,367 36,127 744,221 4.9 3.8 202015 2,659 1,459 3,377 9,947 6,024 4,003 24,810 711,375 3.5 2.8 202016 2,637 1,028 2,612 7,393 4,166 2,909 18,108 701,841 2.6 2.1 202017 2,615 891 2,279 6,303 3,273 2,282 15,028 741,674 2.0 1.7 202018 2,581 850 2,080 5,258 2,657 1,879 12,724 781,054 1.6 1.4 202019 2,563 705 1,868 4,531 2,206 1,609 10,919 806,452 1.4 1.2 202020 2,543 778 1,956 4,088 2,137 1,426 10,385 844,666 1.2 1.1 202021 2,813 872 2,188 4,355 2,120 1,567 11,102 1,045,008 1.1 1.0 202022 2,779 773 1,842 3,479 1,809 1,403 9,306 1,077,482 .9 .8 202023 2,652 727 1,815 3,149 1,570 1,285 8,546 1,100,717 .8 .7

Totals 1,820,542 45,400,767


HHS Region 1 (CT, ME, MA, NH, RI, and VT) (Baseline: 1.9%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 255 247 404 324 174 112 1,261 130,089 1.0 .9 201941 261 274 441 396 178 176 1,465 130,676 1.1 1.0 201942 265 313 501 436 179 163 1,592 129,402 1.2 1.1 201943 262 318 513 400 187 153 1,571 133,141 1.2 1.1 201944 271 333 570 389 187 164 1,643 132,506 1.2 1.1 201945 263 390 662 456 162 140 1,810 131,409 1.4 1.3 201946 261 463 681 470 197 136 1,947 127,939 1.5 1.4 201947 264 537 744 515 227 153 2,176 131,725 1.7 1.5 201948 263 621 700 497 216 191 2,225 111,608 2.0 1.8 201949 264 604 742 633 268 225 2,472 124,372 2.0 1.8 201950 263 631 881 630 269 218 2,629 130,387 2.0 1.9 201951 262 844 1,085 819 300 242 3,290 124,306 2.6 2.5 201952 264 946 1,448 1,278 489 402 4,563 115,551 3.9 3.7 202001 263 980 1,378 1,834 675 525 5,392 126,621 4.3 3.9 202002 270 821 1,618 1,707 690 473 5,309 135,907 3.9 3.7 202003 268 976 2,403 1,762 641 427 6,209 132,162 4.7 4.5 202004 265 1,109 3,149 2,156 776 446 7,636 134,954 5.7 5.3 202005 267 1,253 4,226 2,932 947 593 9,951 146,905 6.8 6.4 202006 266 1,328 4,749 3,147 1,056 610 10,890 143,279 7.6 7.2 202007 265 1,147 3,800 2,836 907 568 9,258 139,224 6.6 6.5 202008 267 989 2,741 2,406 956 597 7,689 129,858 5.9 5.7 202009 259 806 2,027 2,081 852 539 6,305 132,556 4.8 4.6 202010 262 758 1,903 1,921 829 523 5,934 129,286 4.6 4.3 202011 244 678 1,831 2,135 873 644 6,161 115,114 5.4 4.8 202012 243 501 1,057 1,963 919 559 4,999 75,667 6.6 5.9 202013 234 192 461 1,356 751 553 3,313 60,644 5.5 4.8 202014 232 76 319 1,151 688 498 2,732 55,605 4.9 4.4 202015 228 44 227 804 555 397 2,027 54,010 3.8 3.4 202016 234 31 214 776 485 376 1,882 55,089 3.4 3.1 202017 219 15 131 542 338 258 1,284 56,017 2.3 2.1 202018 217 33 150 425 212 215 1,035 57,934 1.8 1.7 202019 217 25 127 366 211 164 893 62,506 1.4 1.3 202020 218 33 127 338 220 129 847 64,527 1.3 1.2 202021 219 19 108 260 173 127 687 73,860 .9 .9 202022 215 25 102 225 117 110 579 76,356 .8 .7 202023 208 16 84 182 143 106 531 79,645 .7 .7

Totals 130,187 3,890,837


HHS Region 2 (NJ, NY, PR, and USVI) (Baseline: 3.2%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 263 945 884 642 242 281 2,994 195,431 1.5 2.1 201941 263 969 833 651 284 244 2,981 191,446 1.6 2.1 201942 264 1,187 919 675 313 266 3,360 190,590 1.8 2.4 201943 264 1,133 966 687 306 279 3,371 196,090 1.7 2.0 201944 263 1,368 1,050 700 294 285 3,697 190,727 1.9 2.3 201945 268 1,656 1,197 731 317 294 4,195 193,040 2.2 2.4 201946 259 1,739 1,214 776 362 300 4,391 189,305 2.3 2.7 201947 263 1,775 1,360 874 408 284 4,701 197,786 2.4 2.7 201948 265 2,194 1,513 924 428 311 5,370 178,473 3.0 3.3 201949 264 2,260 1,743 1,134 469 381 5,987 193,324 3.1 3.2 201950 260 2,403 2,456 1,397 517 372 7,145 198,649 3.6 3.7 201951 265 2,791 3,466 1,644 645 452 8,998 195,553 4.6 4.8 201952 256 3,543 4,398 2,823 998 733 12,495 190,159 6.6 6.7 202001 259 3,620 3,439 3,653 1,309 994 13,015 197,077 6.6 6.8 202002 261 2,670 3,356 3,284 1,192 826 11,328 192,960 5.9 6.2 202003 264 2,993 4,912 3,058 1,168 775 12,906 198,529 6.5 6.8 202004 259 3,487 6,027 3,476 1,270 814 15,074 205,685 7.3 7.6 202005 263 3,391 6,742 3,857 1,288 844 16,122 210,374 7.7 7.8 202006 269 3,225 6,823 3,516 1,291 829 15,684 210,880 7.4 7.9 202007 256 2,687 5,076 2,817 1,073 724 12,377 196,877 6.3 6.8 202008 257 2,203 3,120 2,445 917 656 9,341 181,405 5.1 5.8 202009 255 1,828 2,456 2,107 781 596 7,768 183,170 4.2 5.0 202010 256 1,893 2,850 2,586 1,010 651 8,990 181,047 5.0 5.5 202011 252 2,094 4,028 4,572 1,912 1,036 13,642 189,163 7.2 7.6 202012 239 1,395 2,592 7,383 3,268 1,840 16,478 148,990 11.1 11.2 202013 221 604 1,402 7,459 4,371 2,408 16,244 128,542 12.6 11.9 202014 236 257 805 5,228 3,938 2,254 12,482 116,828 10.7 10.5 202015 239 159 549 2,806 2,393 1,611 7,518 100,403 7.5 7.8 202016 243 91 354 1,690 1,350 988 4,473 90,925 4.9 5.2 202017 239 88 281 1,087 737 593 2,786 90,420 3.1 3.5 202018 236 88 228 715 542 393 1,966 92,886 2.1 2.5 202019 235 68 176 466 311 289 1,310 92,222 1.4 1.9 202020 239 112 202 419 291 237 1,261 102,473 1.2 1.8 202021 200 80 141 319 234 174 948 98,633 1.0 1.4 202022 192 89 120 252 167 148 776 104,410 .7 1.2 202023 223 81 137 265 149 184 816 114,579 .7 1.1

Totals 272,990 5,929,051


HHS Region 3 (DE, DC, MD, PA, VA, and WV) (Baseline: 1.9%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 416 797 1,055 754 267 182 3,055 234,770 1.3 1.2 201941 423 874 1,137 844 331 250 3,436 237,191 1.4 1.3 201942 418 986 1,118 842 338 270 3,554 227,164 1.6 1.4 201943 431 1,079 1,322 1,044 382 256 4,083 239,162 1.7 1.6 201944 421 1,133 1,338 929 350 251 4,001 234,242 1.7 1.5 201945 429 1,265 1,405 1,069 391 249 4,379 234,584 1.9 1.7 201946 420 1,362 1,630 1,158 415 268 4,833 230,308 2.1 1.9 201947 423 1,567 1,931 1,251 516 298 5,563 241,623 2.3 2.1 201948 421 1,858 1,887 1,346 480 345 5,916 212,108 2.8 2.4 201949 414 1,584 2,155 1,780 549 394 6,462 235,580 2.7 2.4 201950 421 1,960 3,221 2,086 632 453 8,352 238,415 3.5 3.0 201951 421 2,378 4,726 2,728 774 541 11,147 241,177 4.6 3.9 201952 423 3,347 5,743 4,101 1,211 878 15,280 230,061 6.6 5.6 202001 421 3,240 4,229 5,062 1,565 1,190 15,286 247,495 6.2 5.5 202002 424 2,233 3,595 4,047 1,311 901 12,087 247,105 4.9 4.4 202003 426 2,259 4,403 3,677 1,194 764 12,297 245,508 5.0 4.6 202004 420 2,485 5,202 4,099 1,396 735 13,917 239,344 5.8 5.3 202005 425 2,774 6,891 5,385 1,748 872 17,670 256,167 6.9 6.3 202006 424 2,740 7,200 5,763 1,938 1,053 18,694 257,695 7.3 6.5 202007 423 2,593 6,348 5,466 1,889 1,057 17,353 272,338 6.4 5.8 202008 426 2,277 4,986 4,674 1,710 891 14,538 246,032 5.9 5.3 202009 420 2,126 4,702 4,671 1,706 921 14,126 248,312 5.7 5.2 202010 417 2,069 4,777 4,944 1,835 1,102 14,727 262,206 5.6 5.1 202011 416 2,287 4,976 6,065 2,380 1,251 16,959 256,511 6.6 6.1 202012 416 1,788 3,065 5,201 2,077 1,117 13,248 189,566 7.0 6.8 202013 411 886 1,297 3,147 1,404 794 7,528 148,795 5.1 4.9 202014 392 370 800 2,097 1,071 673 5,011 129,753 3.9 3.8 202015 385 270 535 1,750 834 524 3,913 125,094 3.1 3.0 202016 374 159 452 1,467 681 419 3,178 121,390 2.6 2.4 202017 402 129 420 1,440 639 362 2,990 135,525 2.2 2.0 202018 393 121 388 1,386 594 354 2,843 142,430 2.0 1.8 202019 387 121 360 1,121 524 290 2,416 146,696 1.6 1.5 202020 382 120 350 938 472 258 2,138 152,510 1.4 1.3 202021 370 140 349 849 378 248 1,964 158,557 1.2 1.1 202022 366 77 237 544 310 223 1,391 161,440 .9 .8 202023 354 63 222 438 229 176 1,128 165,328 .7 .7

Totals 295,463 7,592,182


HHS Region 4 (AL, FL, GA, KY, MS, NC, SC, and TN) (Baseline: 2.4%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 560 1,783 1,971 1,234 364 284 5,636 333,396 1.7 1.7 201941 557 1,757 1,710 1,219 376 288 5,350 317,589 1.7 1.6 201942 571 1,831 1,871 1,338 397 303 5,740 312,547 1.8 1.8 201943 574 2,107 2,211 1,496 507 362 6,683 322,052 2.1 2.0 201944 580 2,300 2,475 1,507 492 345 7,119 318,970 2.2 2.3 201945 584 2,917 3,174 1,906 555 383 8,935 323,507 2.8 2.9 201946 579 3,154 3,432 2,072 677 422 9,757 312,438 3.1 3.1 201947 566 3,301 4,481 2,491 708 450 11,431 315,660 3.6 3.3 201948 572 4,046 4,299 2,617 847 597 12,406 294,185 4.2 4.2 201949 578 3,828 4,646 3,486 1,046 693 13,699 331,928 4.1 4.0 201950 575 3,945 6,626 3,925 1,168 683 16,347 327,859 5.0 5.0 201951 553 5,243 9,285 5,352 1,453 850 22,183 323,870 6.8 6.4 201952 558 7,471 10,306 8,313 2,525 1,524 30,139 321,109 9.4 8.8 202001 567 5,901 6,142 8,235 2,700 1,801 24,779 329,997 7.5 6.8 202002 568 3,709 5,425 6,268 2,007 1,185 18,594 328,884 5.7 5.2 202003 569 3,886 7,017 5,380 1,769 997 19,049 327,657 5.8 5.4 202004 576 4,128 7,560 5,596 1,718 911 19,913 323,326 6.2 6.4 202005 566 4,795 10,112 7,334 2,275 1,137 25,653 341,638 7.5 7.5 202006 570 5,062 10,963 7,999 2,457 1,252 27,733 352,234 7.9 7.3 202007 564 3,864 7,870 6,528 2,145 1,150 21,557 333,750 6.5 6.3 202008 574 2,994 5,583 4,947 1,510 907 15,941 285,138 5.6 5.4 202009 566 2,708 5,285 4,989 1,686 953 15,621 311,004 5.0 4.8 202010 560 3,153 6,125 5,448 1,869 1,027 17,622 325,409 5.4 5.4 202011 538 3,245 6,535 6,758 2,352 1,349 20,239 315,593 6.4 5.8 202012 535 2,776 4,190 6,472 2,408 1,244 17,090 249,146 6.9 5.9 202013 532 1,442 2,076 4,064 1,599 989 10,170 196,528 5.2 4.3 202014 516 700 1,170 2,390 957 680 5,897 165,823 3.6 3.1 202015 510 420 789 1,654 783 533 4,179 157,778 2.6 2.0 202016 503 308 585 1,263 577 421 3,154 156,987 2.0 1.6 202017 489 260 498 1,089 516 401 2,764 162,769 1.7 1.2 202018 489 217 424 919 460 317 2,337 169,127 1.4 1.0 202019 489 199 397 930 387 334 2,247 183,824 1.2 .9 202020 485 206 476 850 433 287 2,252 190,906 1.2 .8 202021 812 305 794 1,390 677 596 3,762 354,561 1.1 1.0 202022 803 313 737 1,351 659 483 3,543 364,258 1.0 1.0 202023 765 291 747 1,260 572 447 3,317 365,552 .9 .9

Totals 442,838 10,446,999


HHS Region 5 (IL, IN, MI, MN, OH, and WI) (Baseline: 1.9%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 393 558 741 354 139 124 1,916 162,310 1.2 1.1 201941 398 647 754 400 180 156 2,137 155,532 1.4 1.3 201942 398 736 837 416 189 142 2,320 159,980 1.5 1.3 201943 412 803 894 509 232 157 2,595 170,600 1.5 1.4 201944 411 796 927 510 197 150 2,580 166,324 1.6 1.4 201945 417 859 974 519 215 165 2,732 170,288 1.6 1.5 201946 418 872 906 546 208 188 2,720 164,128 1.7 1.5 201947 416 935 1,126 545 228 178 3,012 169,491 1.8 1.6 201948 418 1,182 1,016 509 208 173 3,088 146,700 2.1 2.0 201949 419 1,329 1,312 727 281 205 3,854 175,439 2.2 2.1 201950 412 1,466 1,588 740 272 209 4,275 165,201 2.6 2.4 201951 415 1,732 2,043 942 322 231 5,270 154,007 3.4 3.2 201952 410 2,161 2,382 1,390 427 327 6,687 133,670 5.0 4.8 202001 412 2,144 1,725 1,591 526 424 6,410 154,720 4.1 3.5 202002 415 1,648 1,863 1,478 550 353 5,892 166,031 3.5 3.2 202003 415 1,639 2,410 1,282 460 274 6,065 166,088 3.7 3.2 202004 420 1,929 3,449 1,691 515 289 7,873 168,886 4.7 4.3 202005 413 2,326 4,566 2,188 682 385 10,147 177,784 5.7 5.2 202006 416 2,319 4,996 2,480 832 419 11,046 177,940 6.2 5.7 202007 412 2,060 4,192 2,334 757 407 9,750 168,943 5.8 5.4 202008 405 1,885 3,601 2,389 788 455 9,118 170,030 5.4 4.9 202009 402 1,642 3,108 2,086 791 520 8,147 165,527 4.9 4.6 202010 406 1,559 2,866 2,294 856 595 8,170 170,584 4.8 4.5 202011 389 1,478 2,718 2,611 872 542 8,221 149,985 5.5 4.6 202012 391 1,146 1,742 2,432 936 463 6,719 110,732 6.1 4.6 202013 372 464 665 1,523 615 313 3,580 81,062 4.4 3.1 202014 365 213 397 1,028 504 232 2,374 72,359 3.3 2.2 202015 374 127 311 839 435 212 1,924 77,768 2.5 1.8 202016 371 90 273 721 384 170 1,638 78,793 2.1 1.4 202017 370 102 282 740 376 172 1,672 88,541 1.9 1.5 202018 360 95 271 719 328 151 1,564 91,546 1.7 1.4 202019 345 73 262 633 280 144 1,392 91,691 1.5 1.2 202020 343 92 299 636 240 131 1,398 94,863 1.5 1.3 202021 325 80 256 598 211 96 1,241 96,429 1.3 .9 202022 327 44 132 281 145 105 707 101,928 .7 .5 202023 279 52 124 208 111 60 555 92,216 .6 .5

Totals 158,789 5,008,116


HHS Region 6 (AR, LA, NM, OK, and TX) (Baseline: 3.8%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 309 1,110 1,249 671 217 140 3,387 122,699 2.8 2.2 201941 307 1,184 1,327 739 228 155 3,633 121,390 3.0 2.5 201942 311 1,193 1,488 863 260 151 3,955 121,617 3.3 2.7 201943 313 1,392 1,801 980 255 185 4,613 122,600 3.8 3.2 201944 315 1,616 2,151 1,157 332 207 5,463 120,455 4.5 3.7 201945 316 2,087 3,119 1,458 368 222 7,254 127,147 5.7 4.7 201946 306 2,346 3,491 1,739 396 243 8,215 125,373 6.6 5.0 201947 309 2,752 4,632 2,136 515 325 10,360 133,630 7.8 6.3 201948 309 2,625 3,147 2,018 518 315 8,623 108,631 7.9 6.9 201949 304 2,059 2,834 2,234 598 349 8,074 125,317 6.4 5.8 201950 283 2,022 3,209 1,883 488 326 7,928 112,757 7.0 7.7 201951 276 2,226 3,774 2,045 525 340 8,910 106,476 8.4 10.1 201952 273 3,032 4,163 3,066 827 569 11,657 104,199 11.2 13.5 202001 297 2,391 2,796 3,434 1,070 746 10,437 112,117 9.3 10.0 202002 308 1,868 2,933 3,282 1,079 576 9,738 121,644 8.0 8.8 202003 305 2,107 3,774 3,098 955 528 10,462 122,544 8.5 9.7 202004 308 2,300 4,306 3,115 974 514 11,209 124,949 9.0 9.9 202005 309 2,532 5,163 3,626 1,170 611 13,102 130,917 10.0 10.7 202006 308 2,381 4,697 3,339 1,084 530 12,031 119,456 10.1 10.3 202007 303 2,164 4,303 3,318 1,101 538 11,424 123,799 9.2 9.4 202008 304 2,076 3,864 3,174 1,070 602 10,786 124,635 8.7 8.7 202009 297 2,092 3,405 2,961 1,012 546 10,016 120,902 8.3 8.0 202010 295 1,851 3,267 3,105 1,036 638 9,897 124,400 8.0 7.8 202011 291 1,843 3,086 3,228 1,191 692 10,040 117,945 8.5 7.2 202012 279 1,371 2,298 3,538 1,387 771 9,365 96,575 9.7 8.3 202013 276 726 1,087 2,409 1,057 669 5,948 72,126 8.2 5.7 202014 267 340 585 1,448 727 505 3,605 59,728 6.0 4.2 202015 273 211 434 950 441 381 2,417 57,668 4.2 3.2 202016 269 160 337 684 317 236 1,734 55,232 3.1 2.3 202017 262 164 291 652 275 208 1,590 57,479 2.8 2.2 202018 253 127 242 493 228 186 1,276 59,918 2.1 1.6 202019 262 118 240 453 207 151 1,169 62,628 1.9 1.4 202020 257 118 201 410 202 165 1,096 65,970 1.7 1.3 202021 286 143 217 425 205 142 1,132 79,300 1.4 1.2 202022 277 116 224 353 186 138 1,017 78,969 1.3 1.1 202023 258 128 229 340 167 124 988 74,428 1.3 1.0

Totals 242,551 3,715,620


HHS Region 7 (IA, KS, MO, and NE) (Baseline: 1.7%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 130 109 166 72 25 16 388 36,003 1.1 .8 201941 132 129 189 73 32 26 449 35,517 1.3 .8 201942 130 174 237 93 26 23 553 37,930 1.5 1.0 201943 132 174 242 87 37 30 570 38,236 1.5 1.1 201944 132 176 212 83 40 32 543 35,531 1.5 1.2 201945 132 180 246 107 35 34 602 37,506 1.6 1.2 201946 132 257 261 109 47 30 704 36,610 1.9 1.7 201947 132 307 315 93 37 32 784 38,745 2.0 1.5 201948 130 402 261 130 65 51 909 29,265 3.1 1.7 201949 133 405 351 223 70 43 1,092 38,718 2.8 1.8 201950 133 452 502 273 85 53 1,365 37,677 3.6 2.2 201951 132 455 687 301 91 65 1,599 35,002 4.6 2.8 201952 129 677 870 525 153 102 2,327 28,680 8.1 5.6 202001 130 616 613 598 187 146 2,160 31,432 6.9 4.8 202002 129 457 566 528 186 114 1,851 33,939 5.5 3.6 202003 129 443 790 404 112 87 1,836 33,324 5.5 5.3 202004 129 412 848 411 125 62 1,858 34,151 5.4 6.1 202005 128 430 1,097 418 144 81 2,170 35,795 6.1 6.9 202006 129 456 1,231 471 127 107 2,392 36,735 6.5 7.3 202007 128 437 1,039 497 188 124 2,285 35,478 6.4 6.4 202008 129 449 942 481 182 113 2,167 36,125 6.0 5.9 202009 127 396 767 388 185 121 1,857 33,287 5.6 6.7 202010 126 411 798 395 149 133 1,886 34,946 5.4 7.0 202011 123 394 635 492 179 119 1,819 32,103 5.7 6.5 202012 120 328 368 531 194 95 1,516 24,793 6.1 5.9 202013 117 144 185 318 136 75 858 19,738 4.3 3.7 202014 117 48 102 216 98 69 533 17,283 3.1 2.0 202015 117 26 59 152 64 44 345 16,019 2.2 1.4 202016 114 33 44 108 36 29 250 16,007 1.6 1.0 202017 114 11 48 103 43 39 244 17,368 1.4 .8 202018 114 25 44 87 32 30 218 18,614 1.2 1.0 202019 110 8 28 76 33 26 171 18,919 .9 .5 202020 108 15 34 67 44 11 171 19,595 .9 .5 202021 105 13 26 59 22 21 141 19,968 .7 .4 202022 105 11 21 55 25 22 134 17,443 .8 .4 202023 98 16 27 58 19 19 139 19,802 .7 .4

Totals 38,886 1,068,284


HHS Region 8 (CO, MT, ND, SD, UT, and WY) (Baseline: 2.7%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 223 325 525 369 132 113 1,464 89,062 1.6 1.8 201941 229 332 511 380 162 120 1,505 94,226 1.6 1.8 201942 232 427 513 416 167 132 1,655 98,201 1.7 1.9 201943 231 402 554 430 166 164 1,716 96,380 1.8 2.0 201944 232 382 485 398 169 131 1,565 86,690 1.8 2.0 201945 227 511 603 392 146 122 1,774 93,003 1.9 2.1 201946 228 496 662 416 176 140 1,890 85,341 2.2 2.4 201947 228 603 775 465 170 149 2,162 89,171 2.4 2.6 201948 228 684 682 469 158 130 2,123 70,708 3.0 3.2 201949 230 676 790 567 210 159 2,402 86,046 2.8 3.0 201950 224 651 1,055 658 229 200 2,793 83,098 3.4 3.6 201951 223 893 1,368 793 248 232 3,534 86,211 4.1 4.4 201952 229 1,062 1,673 1,217 401 328 4,681 78,163 6.0 6.3 202001 227 1,054 1,200 1,176 434 367 4,231 77,108 5.5 5.8 202002 228 959 1,371 1,226 394 373 4,323 86,878 5.0 5.2 202003 223 1,030 1,711 1,161 389 342 4,633 86,732 5.3 5.6 202004 222 1,279 2,079 1,402 476 320 5,556 88,887 6.3 6.5 202005 224 1,318 2,429 1,463 529 363 6,102 92,522 6.6 6.8 202006 225 1,209 2,178 1,470 525 345 5,727 89,352 6.4 6.7 202007 221 1,058 1,740 1,179 477 355 4,809 86,262 5.6 5.9 202008 225 1,030 1,541 1,141 434 331 4,477 84,564 5.3 5.5 202009 224 909 1,432 1,163 480 323 4,307 89,104 4.8 5.0 202010 211 894 1,445 1,277 485 387 4,488 87,220 5.1 5.2 202011 215 852 1,645 1,647 645 377 5,166 84,775 6.1 6.3 202012 215 534 826 1,315 461 315 3,451 58,589 5.9 6.2 202013 208 238 372 727 273 190 1,800 48,114 3.7 4.0 202014 210 130 241 489 227 115 1,202 44,122 2.7 2.9 202015 208 72 181 340 152 84 829 41,647 2.0 2.1 202016 199 51 93 253 96 62 555 43,367 1.3 1.4 202017 199 47 112 221 88 66 534 45,085 1.2 1.2 202018 203 36 87 163 70 48 404 47,344 .9 .9 202019 201 40 92 131 72 44 379 48,386 .8 .8 202020 201 37 91 130 49 41 348 49,860 .7 .7 202021 199 33 87 137 51 32 340 52,846 .6 .6 202022 197 38 87 128 48 39 340 51,870 .7 .6 202023 191 29 87 117 35 31 299 55,976 .5 .5

Totals 93,564 2,676,910


HHS Region 9 (AZ, CA, HI, and NV) (Baseline: 2.4%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older

Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 195 251 436 184 107 98 1,076 82,844 1.3 1.3 201941 194 257 465 211 128 97 1,158 81,621 1.4 1.5 201942 199 282 537 205 137 114 1,275 80,978 1.6 1.6 201943 199 316 571 238 138 129 1,392 84,077 1.7 1.7 201944 200 371 595 265 133 116 1,480 82,073 1.8 1.8 201945 205 499 880 317 163 164 2,023 87,475 2.3 2.3 201946 207 567 1,095 411 179 160 2,412 90,242 2.7 2.6 201947 206 583 1,059 442 182 188 2,454 94,874 2.6 2.5 201948 204 518 762 413 175 165 2,033 67,070 3.0 2.9 201949 208 588 901 617 277 207 2,590 92,045 2.8 2.8 201950 206 568 971 503 236 225 2,503 89,739 2.8 2.8 201951 202 633 956 596 225 224 2,634 84,369 3.1 3.2 201952 204 723 892 670 273 258 2,816 65,035 4.3 4.6 202001 214 776 748 850 377 358 3,109 76,904 4.0 4.6 202002 214 641 1,151 872 442 401 3,507 101,190 3.5 3.8 202003 209 679 1,451 868 414 353 3,765 101,236 3.7 4.1 202004 212 828 1,761 923 432 397 4,341 100,529 4.3 4.7 202005 213 896 1,975 906 435 392 4,604 107,023 4.3 4.7 202006 209 971 1,884 992 452 397 4,696 107,691 4.4 4.8 202007 209 803 1,697 793 390 345 4,028 100,082 4.0 4.5 202008 211 778 1,347 867 471 432 3,895 99,016 3.9 4.3 202009 205 660 1,398 875 413 373 3,719 102,534 3.6 3.9 202010 187 651 1,206 741 314 300 3,212 96,366 3.3 3.7 202011 180 577 1,071 844 375 320 3,187 87,530 3.6 4.0 202012 175 366 560 700 293 234 2,153 55,644 3.9 4.6 202013 171 180 327 555 258 219 1,539 49,738 3.1 3.5 202014 161 103 201 361 193 193 1,051 43,667 2.4 2.6 202015 161 59 129 268 182 115 753 41,804 1.8 2.0 202016 166 46 131 199 134 127 637 44,655 1.4 1.5 202017 158 33 119 177 122 101 552 46,178 1.2 1.3 202018 155 30 104 153 111 104 502 44,880 1.1 1.1 202019 158 26 100 167 98 85 476 53,171 .9 1.0 202020 152 26 88 130 90 108 442 55,943 .8 .8 202021 139 31 131 142 95 84 483 61,633 .8 .8 202022 136 32 98 147 81 74 432 68,092 .6 .7 202023 117 17 66 121 78 75 357 80,911 .4 .5

Totals 77,286 2,808,859


HHS Region 10 (AK, ID, OR, and WA) (Baseline: 1.5%)

CDC Week

# Sites Reporting

ILI 0-4 years

ILI 5-24 years

ILI 25-49 years

ILI 50-64 years

ILI 65 years

and older Total ILI

Total Patient

Visits

% Unweighted

ILI

% Weighted

ILI 201940 166 94 227 223 95 99 738 71,045 1.0 1.0 201941 178 129 270 237 116 92 844 71,305 1.2 1.1 201942 178 160 275 265 105 87 892 72,289 1.2 1.2 201943 179 169 280 211 95 79 834 71,238 1.2 1.1 201944 181 185 273 207 85 83 833 68,251 1.2 1.2 201945 180 195 295 225 101 70 886 64,848 1.4 1.3 201946 179 192 304 212 83 83 874 64,886 1.3 1.4 201947 178 356 633 326 109 91 1,515 72,024 2.1 2.2 201948 183 316 554 286 104 94 1,354 56,732 2.4 2.8 201949 180 524 921 544 161 124 2,274 73,068 3.1 3.3 201950 180 634 1,374 729 219 166 3,122 74,636 4.2 4.5 201951 176 810 1,796 1,012 252 172 4,042 73,132 5.5 5.8 201952 169 1,139 2,127 1,233 331 285 5,115 71,965 7.1 7.2 202001 175 905 1,143 1,213 364 325 3,950 71,870 5.5 5.7 202002 179 562 869 940 345 264 2,980 73,781 4.0 4.1 202003 178 540 767 711 272 183 2,473 70,333 3.5 3.6 202004 177 622 889 770 283 180 2,744 72,732 3.8 3.8 202005 177 586 900 766 299 199 2,750 73,329 3.8 3.9 202006 178 568 803 654 283 155 2,463 72,597 3.4 3.5 202007 176 576 826 657 288 184 2,531 73,331 3.5 3.4 202008 174 650 806 667 278 200 2,601 73,118 3.6 3.6 202009 175 612 853 781 354 214 2,814 72,963 3.9 3.9 202010 178 645 1,149 1,186 501 344 3,825 72,812 5.3 5.6 202011 175 657 1,177 1,280 534 363 4,011 68,179 5.9 5.8 202012 170 538 779 1,238 518 339 3,412 54,189 6.3 5.9 202013 166 229 411 816 350 240 2,046 43,511 4.7 4.3 202014 165 117 219 486 270 148 1,240 39,053 3.2 3.1 202015 164 71 163 384 185 102 905 39,184 2.3 2.1 202016 164 59 129 232 106 81 607 39,396 1.5 1.8 202017 163 42 97 252 139 82 612 42,292 1.4 1.7 202018 161 78 142 198 80 81 579 56,375 1.0 1.2 202019 159 27 86 188 83 82 466 46,409 1.0 1.2 202020 158 19 88 170 96 59 432 48,019 .9 1.1 202021 157 28 79 176 74 47 404 48,992 .8 .6 202022 160 28 84 143 71 61 387 52,562 .7 .9 202023 158 33 92 160 67 63 415 52,112 .8 .7

Totals 67,970 2,262,558


U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet): Percentage of Visits for ILI by Age Group Reported by A Subset of ILINet Providers

September 29, 2019 – June 6, 2020 Data as of June 11, 2020 National

Week 0-4 years 5-24 years 25-49 years 50-64 years 65+ years Total

% ILI Total

% ILI Total

% ILI Total

% ILI Total

% ILI

201940 56,425 6.0 172,613 2.4 249,835 1.2 135,200 0.7 150,920 0.5

201941 58,796 6.2 171,544 2.4 247,783 1.3 136,850 0.8 154,875 0.6

201942 59,998 6.8 166,934 2.7 242,650 1.4 135,354 0.9 154,625 0.6

201943 61,136 7.1 176,231 2.9 249,931 1.5 139,369 0.9 158,148 0.6

201944 63,547 7.4 171,729 3.1 245,723 1.5 133,493 0.9 151,858 0.6

201945 66,254 8.4 174,035 3.7 243,311 1.7 133,090 1.0 151,920 0.6

201946 67,301 9.3 170,191 4.2 240,821 2.0 131,489 1.2 148,155 0.7

201947 73,344 9.7 177,139 5.0 253,460 2.2 138,845 1.3 154,044 0.8

201948 74,382 11.1 152,778 5.3 231,731 2.4 127,018 1.4 148,199 0.9

201949 73,293 10.6 175,105 4.9 255,541 2.8 136,885 1.6 155,906 1.0

201950 76,087 10.8 183,535 6.1 254,931 3.0 137,872 1.7 155,624 1.0

201951 81,387 12.4 183,296 8.3 251,896 3.7 135,149 1.9 155,485 1.2

201952 90,324 15.9 170,254 11.5 258,698 5.9 140,840 3.2 165,273 2.0

202001 86,651 14.7 162,694 8.4 279,484 5.9 148,891 3.5 169,551 2.4

202002 72,333 12.3 173,029 7.0 272,941 5.1 146,950 3.1 164,628 1.9

202003 73,364 12.8 183,354 8.1 265,744 4.8 143,156 2.9 159,616 1.7

202004 75,504 13.8 186,056 9.4 265,445 5.3 141,943 3.3 157,351 1.7

202005 78,751 14.6 208,490 10.5 277,215 6.3 144,666 3.9 159,926 2.0

202006 78,446 15.0 207,999 11.2 275,227 6.8 146,203 4.2 159,039 2.1

202007 75,486 13.5 196,641 9.7 273,694 6.1 147,936 3.8 162,377 2.0

202008 68,237 13.1 174,298 8.6 250,361 5.7 136,389 3.8 150,935 2.1

202009 67,895 11.8 179,797 7.4 261,054 5.4 141,919 3.6 157,724 2.0

202010 69,178 11.8 188,496 7.4 270,308 5.6 146,955 3.8 162,141 2.2

202011 66,469 12.4 185,585 8.4 274,943 6.8 144,200 4.9 150,575 2.7

202012 45,640 13.9 118,217 8.6 230,370 7.7 116,231 6.2 109,799 3.7

202013 29,668 10.2 83,589 5.7 194,313 6.4 99,562 5.8 94,747 3.8

202014 21,637 6.2 70,538 4.0 169,577 5.0 90,498 5.2 87,391 3.3

202015 19,759 4.2 67,195 2.9 157,092 3.7 88,250 3.8 88,938 2.5

202016 19,124 3.0 65,433 2.2 150,661 2.9 85,073 2.8 89,731 1.8

202017 20,274 2.4 71,176 1.8 161,155 2.3 91,744 2.1 97,603 1.4

202018 21,252 2.1 77,096 1.6 167,836 1.9 93,941 1.6 101,775 1.1

202019 22,639 1.7 82,092 1.3 175,315 1.5 100,002 1.3 107,516 0.9

202020 23,939 1.8 86,554 1.3 179,439 1.3 100,900 1.2 110,872 0.7

202021 32,301 1.7 118,397 1.1 253,439 1.1 143,596 0.9 161,091 0.6

202022 33,023 1.5 127,403 1.0 260,836 0.9 146,570 0.8 164,862 0.6

202023 34,416 1.5 133,949 0.9 265,504 0.8 149,605 0.7 168,942 0.5

Totals 2,038,260 5,393,462 8,558,264 4,656,634 5,142,162


National Syndromic Surveillance Program (NSSP): Emergency Department Visits Percentage of Visits for COVID-19-Like Illness (CLI) or Influenza-like Illness (ILI)

September 29, 2019 – June 6, 2020 Data as of June 11, 2020

National

Week Number of Facilities

Reporting

Total Number of ED Visits

CLI Visits ILI Visits

Number Percent of Total Visits Number Percent of Total

Visits 201940 3,328 2,167,522 23,109 1.1 19,731 0.9 201941 3,321 2,122,370 24,062 1.1 20,607 1.0 201942 3,330 2,116,873 26,446 1.2 22,678 1.1 201943 3,327 2,137,965 27,534 1.3 23,930 1.1 201944 3,364 2,096,045 29,262 1.4 25,628 1.2 201945 3,380 2,144,483 33,916 1.6 30,138 1.4 201946 3,393 2,128,623 36,246 1.7 32,614 1.5 201947 3,407 2,216,504 39,286 1.8 36,249 1.6 201948 3,407 2,105,139 43,055 2.0 39,923 1.9 201949 3,410 2,232,432 41,826 1.9 37,863 1.7 201950 3,419 2,246,358 44,039 2.0 42,642 1.9 201951 3,417 2,230,108 49,688 2.2 51,057 2.3 201952 3,418 2,337,388 64,417 2.8 68,795 2.9 202001 3,439 2,414,783 58,874 2.4 57,785 2.4 202002 3,440 2,299,607 43,510 1.9 42,798 1.9 202003 3,436 2,270,254 42,443 1.9 44,792 2.0 202004 3,465 2,267,926 46,142 2.0 49,804 2.2 202005 3,478 2,360,675 54,135 2.3 59,928 2.5 202006 3,470 2,348,757 53,301 2.3 59,253 2.5 202007 3,493 2,283,017 47,526 2.1 51,115 2.2 202008 3,492 2,268,137 44,150 1.9 46,193 2.0 202009 3,502 2,232,604 40,946 1.8 42,026 1.9 202010 3,513 2,260,163 49,565 2.2 50,071 2.2 202011 3,520 2,245,847 76,904 3.4 71,681 3.2 202012 3,513 1,802,175 107,837 6.0 84,679 4.7 202013 3,528 1,447,991 99,678 6.9 62,520 4.3 202014 3,528 1,261,871 87,240 6.9 43,989 3.5 202015 3,520 1,200,206 72,899 6.1 30,277 2.5 202016 3,522 1,178,788 59,175 5.0 21,427 1.8 202017 3,512 1,248,573 53,272 4.3 17,545 1.4 202018 3,520 1,304,968 48,857 3.7 14,947 1.1 202019 3,517 1,367,002 42,697 3.1 12,632 0.9 202020 3,522 1,416,036 38,991 2.8 11,846 0.8 202021 3,537 1,517,612 35,883 2.4 11,326 0.7 202022 3,563 1,611,265 31,727 2.0 10,065 0.6 202023 3,560 1,654,968 27,061 1.6 9,789 0.6

Total 70,545,035 1,745,699 1,358,343




Reporting




Visits

201940 203 132,282 1,032 0.8 749 0.6

201941 203 130,417 1,121 0.9 814 0.6

201942 202 132,426 1,208 0.9 912 0.7

201943 202 131,897 1,249 0.9 883 0.7

201944 203 128,286 1,203 0.9 888 0.7

201945 203 127,500 1,365 1.1 979 0.8

201946 202 125,338 1,538 1.2 1,188 0.9

201947 202 128,917 1,547 1.2 1,235 1.0

201948 203 124,825 1,795 1.4 1,452 1.2

201949 203 125,986 1,837 1.5 1,362 1.1

201950 202 130,488 1,789 1.4 1,405 1.1

201951 203 126,356 1,964 1.6 1,704 1.3

201952 203 136,139 2,734 2.0 2,483 1.8

202001 203 144,641 2,902 2.0 2,568 1.8

202002 202 140,162 2,349 1.7 2,192 1.6

202003 202 134,819 2,423 1.8 2,452 1.8

202004 202 139,784 2,732 2.0 2,945 2.1

202005 202 146,400 3,254 2.2 3,497 2.4

202006 202 143,974 3,223 2.2 3,612 2.5

202007 202 138,242 2,729 2.0 2,845 2.1

202008 202 132,297 2,307 1.7 2,291 1.7

202009 202 133,050 2,076 1.6 1,913 1.4

202010 199 129,473 2,376 1.8 2,297 1.8

202011 199 123,654 3,893 3.1 3,321 2.7

202012 199 91,554 5,460 6.0 3,607 3.9

202013 201 74,698 5,524 7.4 2,561 3.4

202014 201 67,580 6,163 9.1 2,123 3.1

202015 196 67,220 6,281 9.3 1,654 2.5

202016 195 66,683 5,992 9.0 1,360 2.0

202017 195 71,284 5,799 8.1 1,041 1.5

202018 195 74,455 4,980 6.7 743 1.0

202019 194 79,083 4,256 5.4 683 0.9

202020 193 81,228 3,613 4.4 612 0.8

202021 193 86,040 2,867 3.3 498 0.6

202022 193 90,825 2,180 2.4 416 0.5

202023 193 91,750 1,511 1.6 385 0.4

Total 4,129,753 105,272 61,670




Reporting




Visits

201940 196 225,750 2,136 0.9 1,782 0.8

201941 196 221,826 2,056 0.9 1,787 0.8

201942 195 220,018 2,322 1.1 2,002 0.9

201943 195 224,708 2,362 1.1 2,101 0.9

201944 196 220,738 2,708 1.2 2,342 1.1

201945 195 218,955 2,953 1.3 2,642 1.2

201946 196 215,955 3,260 1.5 2,798 1.3

201947 196 225,696 3,423 1.5 3,055 1.4

201948 196 216,732 3,924 1.8 3,626 1.7

201949 196 224,234 4,059 1.8 3,707 1.7

201950 196 230,493 4,329 1.9 4,122 1.8

201951 195 224,972 4,962 2.2 4,924 2.2

201952 195 239,738 6,489 2.7 6,864 2.9

202001 195 250,150 6,479 2.6 6,740 2.7

202002 195 243,456 4,981 2.0 5,343 2.2

202003 195 238,564 5,057 2.1 5,617 2.4

202004 195 238,687 5,614 2.4 6,432 2.7

202005 195 245,408 6,123 2.5 7,050 2.9

202006 195 241,600 5,816 2.4 6,703 2.8

202007 195 228,905 4,641 2.0 5,203 2.3

202008 195 222,235 3,956 1.8 4,219 1.9

202009 195 222,047 3,567 1.6 3,696 1.7

202010 195 222,257 4,795 2.2 5,000 2.2

202011 195 223,513 9,794 4.4 9,203 4.1

202012 195 188,427 17,822 9.5 14,306 7.6

202013 195 166,927 23,398 14.0 15,271 9.1

202014 194 144,644 23,060 15.9 11,752 8.1

202015 195 123,514 17,938 14.5 7,083 5.7

202016 195 110,070 12,344 11.2 4,053 3.7

202017 195 107,074 8,427 7.9 2,286 2.1

202018 195 110,051 6,370 5.8 1,569 1.4

202019 195 114,397 4,582 4.0 1,083 0.9

202020 195 117,680 3,646 3.1 901 0.8

202021 195 125,818 2,764 2.2 798 0.6

202022 195 134,636 2,115 1.6 613 0.5

202023 195 138,536 1,545 1.1 544 0.4

Total 7,068,411 229,817 167,217




Reporting




Visits

201940 332 233,595 2,038 0.9 1,590 0.7

201941 333 231,169 2,118 0.9 1,619 0.7

201942 334 226,278 2,249 1.0 1,706 0.8

201943 337 231,392 2,295 1.0 1,742 0.8

201944 335 229,710 2,379 1.0 1,814 0.8

201945 335 224,925 2,574 1.1 2,000 0.9

201946 337 225,146 2,830 1.3 2,267 1.0

201947 340 233,879 3,124 1.3 2,451 1.0

201948 341 221,061 3,409 1.5 2,768 1.3

201949 339 233,930 3,362 1.4 2,787 1.2

201950 339 237,404 3,623 1.5 3,138 1.3

201951 341 236,529 4,066 1.7 3,727 1.6

201952 340 250,360 5,399 2.2 5,287 2.1

202001 341 264,053 5,288 2.0 4,652 1.8

202002 340 248,385 3,821 1.5 3,283 1.3

202003 341 243,166 3,592 1.5 3,391 1.4

202004 344 243,765 3,835 1.6 3,850 1.6

202005 346 253,628 4,524 1.8 4,679 1.8

202006 342 253,608 4,398 1.7 4,757 1.9

202007 346 247,526 4,133 1.7 4,054 1.6

202008 346 245,641 3,611 1.5 3,459 1.4

202009 345 243,981 3,582 1.5 3,487 1.4

202010 354 248,328 4,284 1.7 3,971 1.6

202011 354 247,073 6,907 2.8 6,125 2.5

202012 356 191,040 10,092 5.3 7,354 3.8

202013 358 151,792 8,334 5.5 4,863 3.2

202014 360 133,008 7,688 5.8 3,520 2.6

202015 361 128,415 7,673 6.0 2,831 2.2

202016 360 128,681 7,487 5.8 2,254 1.8

202017 360 136,632 7,638 5.6 2,060 1.5

202018 362 144,879 7,566 5.2 1,817 1.3

202019 359 150,048 6,925 4.6 1,566 1.0

202020 367 157,871 6,007 3.8 1,438 0.9

202021 368 170,385 5,662 3.3 1,421 0.8

202022 367 180,393 4,832 2.7 1,099 0.6

202023 367 182,981 3,506 1.9 942 0.5

Total 7,610,657 170,851 109,769




Reporting




Visits

201940 818 612,364 8,566 1.4 7,573 1.2

201941 819 595,875 8,667 1.5 7,872 1.3

201942 823 593,219 9,283 1.6 8,209 1.4

201943 823 602,952 9,906 1.6 8,859 1.5

201944 847 599,483 10,756 1.8 9,893 1.7

201945 849 606,446 12,474 2.1 11,438 1.9

201946 863 596,041 13,192 2.2 12,172 2.0

201947 869 620,324 14,196 2.3 13,276 2.1

201948 869 600,326 15,306 2.5 14,573 2.4

201949 872 634,746 13,946 2.2 12,884 2.0

201950 877 638,941 14,587 2.3 14,754 2.3

201951 878 640,900 16,996 2.7 18,139 2.8

201952 880 661,687 20,782 3.1 22,582 3.4

202001 877 678,509 17,779 2.6 16,780 2.5

202002 879 643,246 12,826 2.0 12,219 1.9

202003 877 650,969 13,138 2.0 13,393 2.1

202004 885 627,132 13,683 2.2 13,723 2.2

202005 886 661,546 16,452 2.5 17,033 2.6

202006 885 675,054 17,056 2.5 17,656 2.6

202007 888 657,786 14,703 2.2 14,823 2.3

202008 887 641,697 13,407 2.1 12,850 2.0

202009 889 625,812 12,481 2.0 11,789 1.9

202010 891 641,735 15,789 2.5 15,013 2.3

202011 895 646,928 23,005 3.6 21,002 3.2

202012 893 528,161 29,304 5.5 23,372 4.4

202013 895 418,920 23,846 5.7 15,692 3.7

202014 893 352,114 17,705 5.0 9,975 2.8

202015 894 333,060 13,673 4.1 6,890 2.1

202016 895 331,687 10,957 3.3 5,092 1.5

202017 891 348,087 9,530 2.7 4,163 1.2

202018 896 357,749 8,673 2.4 3,657 1.0

202019 893 384,314 7,931 2.1 3,188 0.8

202020 896 400,084 7,983 2.0 3,088 0.8

202021 896 425,372 7,909 1.9 2,984 0.7

202022 901 442,240 7,613 1.7 2,904 0.7

202023 900 447,970 7,288 1.6 2,875 0.6

Total 19,923,476 491,388 412,385




Reporting




Visits

201940 694 405,309 3,896 1.0 3,279 0.8

201941 690 394,835 4,241 1.1 3,492 0.9

201942 688 389,610 4,666 1.2 3,871 1.0

201943 690 395,308 4,810 1.2 4,048 1.0

201944 694 381,952 4,819 1.3 3,968 1.0

201945 700 388,204 5,266 1.4 4,277 1.1

201946 698 381,789 5,262 1.4 4,421 1.2

201947 699 402,338 5,831 1.4 4,941 1.2

201948 698 382,083 6,710 1.8 5,820 1.5

201949 699 414,227 7,283 1.8 6,380 1.5

201950 699 411,964 8,158 2.0 7,580 1.8

201951 701 411,850 8,882 2.2 9,043 2.2

201952 700 439,002 12,121 2.8 13,177 3.0

202001 707 451,666 11,232 2.5 11,449 2.5

202002 707 421,908 7,751 1.8 8,012 1.9

202003 709 403,492 7,159 1.8 8,088 2.0

202004 717 415,034 7,951 1.9 9,402 2.3

202005 717 436,244 9,740 2.2 12,382 2.8

202006 716 432,538 9,257 2.1 12,131 2.8

202007 716 413,728 8,198 2.0 10,393 2.5

202008 717 419,693 7,757 1.8 9,810 2.3

202009 718 411,486 7,180 1.7 8,853 2.2

202010 716 418,315 7,672 1.8 9,178 2.2

202011 715 416,618 12,048 2.9 12,646 3.0

202012 716 327,093 18,116 5.5 14,740 4.5

202013 715 258,802 16,601 6.4 9,833 3.8

202014 715 228,944 15,074 6.6 7,086 3.1

202015 712 215,732 12,900 6.0 4,889 2.3

202016 711 211,568 11,296 5.3 3,909 1.8

202017 715 228,938 11,286 4.9 3,614 1.6

202018 712 242,380 11,298 4.7 3,269 1.3

202019 714 249,403 10,044 4.0 2,635 1.1

202020 712 257,165 9,077 3.5 2,412 0.9

202021 715 278,367 8,227 3.0 2,143 0.8

202022 715 299,043 6,653 2.2 1,760 0.6

202023 713 303,942 4,887 1.6 1,624 0.5

Total 12,940,570 313,349 244,555




Reporting




Visits

201940 377 204,866 2,144 1.0 1,897 0.9

201941 375 196,047 2,212 1.1 1,944 1.0

201942 377 197,854 2,581 1.3 2,276 1.2

201943 375 195,070 2,646 1.4 2,460 1.3

201944 378 189,821 2,979 1.6 2,827 1.5

201945 380 208,177 3,916 1.9 3,757 1.8

201946 380 206,267 4,270 2.1 4,108 2.0

201947 386 223,120 5,009 2.2 5,061 2.3

201948 379 207,218 5,163 2.5 4,990 2.4

201949 381 213,228 4,379 2.1 4,070 1.9

201950 384 210,220 4,050 1.9 4,044 1.9

201951 375 205,789 4,432 2.2 4,741 2.3

201952 376 219,829 5,855 2.7 6,463 2.9

202001 383 219,161 4,786 2.2 4,877 2.2

202002 385 205,037 3,587 1.7 3,577 1.7

202003 381 208,301 3,428 1.6 3,664 1.8

202004 386 203,585 3,722 1.8 4,235 2.1

202005 393 208,902 4,221 2.0 4,689 2.2

202006 391 203,112 4,150 2.0 4,496 2.2

202007 401 198,397 3,803 1.9 4,021 2.0

202008 405 200,234 3,742 1.9 3,875 1.9

202009 408 194,541 3,409 1.8 3,422 1.8

202010 409 201,763 4,033 2.0 4,016 2.0

202011 413 204,587 6,257 3.1 5,764 2.8

202012 408 167,567 8,643 5.2 6,793 4.1

202013 413 126,838 7,381 5.8 4,797 3.8

202014 415 113,963 5,873 5.2 3,109 2.7

202015 419 117,827 5,324 4.5 2,471 2.1

202016 418 115,959 3,914 3.4 1,611 1.4

202017 409 124,635 3,586 2.9 1,445 1.2

202018 412 129,841 3,390 2.6 1,341 1.0

202019 408 137,329 3,095 2.3 1,177 0.9

202020 410 141,572 3,084 2.2 1,248 0.9

202021 421 156,132 3,132 2.0 1,198 0.8

202022 439 173,235 3,165 1.8 1,155 0.7

202023 437 192,806 3,408 1.8 1,323 0.7

Total 6,622,830 148,769 122,942




Reporting




Visits

201940 229 84,512 933 1.1 973 1.2

201941 228 80,973 1,037 1.3 1,066 1.3

201942 230 84,368 1,311 1.6 1,378 1.6

201943 229 83,389 1,381 1.7 1,387 1.7

201944 228 78,918 1,330 1.7 1,331 1.7

201945 228 83,340 1,493 1.8 1,520 1.8

201946 225 80,985 1,581 2.0 1,535 1.9

201947 226 86,527 1,819 2.1 1,853 2.1

201948 230 81,876 2,029 2.5 2,065 2.5

201949 230 87,886 2,000 2.3 1,990 2.3

201950 228 87,003 2,239 2.6 2,308 2.7

201951 231 83,719 2,567 3.1 2,691 3.2

201952 232 91,606 3,197 3.5 3,416 3.7

202001 239 92,091 2,812 3.1 2,875 3.1

202002 234 84,568 2,010 2.4 2,025 2.4

202003 236 82,901 1,891 2.3 2,057 2.5

202004 241 82,424 1,837 2.2 2,080 2.5

202005 244 87,684 2,222 2.5 2,558 2.9

202006 242 87,904 2,355 2.7 2,726 3.1

202007 244 87,167 2,520 2.9 2,889 3.3

202008 244 90,115 2,500 2.8 2,794 3.1

202009 247 88,995 2,248 2.5 2,564 2.9

202010 249 88,493 2,234 2.5 2,425 2.7

202011 250 85,788 2,816 3.3 2,852 3.3

202012 251 70,696 3,466 4.9 3,144 4.4

202013 253 58,088 2,613 4.5 2,072 3.6

202014 253 51,037 1,842 3.6 1,294 2.5

202015 251 49,671 1,398 2.8 882 1.8

202016 251 47,404 1,137 2.4 652 1.4

202017 251 51,571 1,100 2.1 620 1.2

202018 251 55,660 1,145 2.1 504 0.9

202019 252 56,769 1,015 1.8 444 0.8

202020 251 58,503 974 1.7 461 0.8

202021 251 63,003 803 1.3 403 0.6

202022 251 67,348 807 1.2 415 0.6

202023 251 69,073 677 1.0 389 0.6

Total 2,752,055 65,339 62,638



Week

Number of Facilities

Reporting Total Number of

ED Visits


Number Percent of Total Visits Number

Percent of Total Visits

201940 153 47,380 367 0.8 285 0.6

201941 154 47,041 431 0.9 303 0.6

201942 153 47,914 436 0.9 333 0.7

201943 151 46,893 385 0.8 340 0.7

201944 156 46,010 427 0.9 316 0.7

201945 158 53,767 592 1.1 477 0.9

201946 159 54,377 606 1.1 484 0.9

201947 155 55,433 698 1.3 630 1.1

201948 158 52,880 844 1.6 752 1.4

201949 158 56,515 731 1.3 633 1.1

201950 163 56,049 814 1.5 765 1.4

201951 162 56,709 913 1.6 919 1.6

201952 158 59,692 1,433 2.4 1,513 2.5

202001 162 63,222 1,263 2.0 1,354 2.1

202002 162 60,883 1,193 2.0 1,165 1.9

202003 162 60,121 1,095 1.8 1,180 2.0

202004 163 62,405 1,334 2.1 1,415 2.3

202005 162 63,956 1,554 2.4 1,680 2.6

202006 166 61,612 1,394 2.3 1,461 2.4

202007 166 61,173 1,276 2.1 1,396 2.3

202008 163 61,834 1,342 2.2 1,456 2.4

202009 164 61,235 1,284 2.1 1,332 2.2

202010 165 62,007 1,435 2.3 1,517 2.4

202011 164 61,649 2,507 4.1 2,295 3.7

202012 162 50,048 3,119 6.2 2,370 4.7

202013 163 42,255 2,805 6.6 1,643 3.9

202014 164 37,704 2,451 6.5 1,222 3.2

202015 161 36,867 1,974 5.4 857 2.3

202016 163 35,460 1,575 4.4 599 1.7

202017 163 39,552 1,588 4.0 536 1.4

202018 164 41,638 1,479 3.6 434 1.0

202019 166 42,059 1,328 3.2 422 1.0

202020 166 43,277 1,231 2.8 350 0.8

202021 167 47,127 1,201 2.5 379 0.8

202022 169 48,994 1,004 2.0 347 0.7

202023 168 48,657 876 1.8 317 0.7

Total 1,874,395 44,985 33,477




Reporting




Visits

201940 135 130,068 1,273 1.0 1,113 0.9

201941 135 132,250 1,464 1.1 1,211 0.9

201942 136 132,260 1,589 1.2 1,375 1.0

201943 137 134,307 1,708 1.3 1,535 1.1

201944 137 133,216 1,888 1.4 1,653 1.2

201945 141 143,855 2,356 1.6 2,304 1.6

201946 142 147,619 2,584 1.8 2,685 1.8

201947 140 144,935 2,514 1.7 2,688 1.9

201948 140 126,374 2,500 2.0 2,527 2.0

201949 139 143,642 2,776 1.9 2,697 1.9

201950 139 145,188 2,720 1.9 2,724 1.9

201951 138 143,693 2,921 2.0 2,929 2.0

201952 140 136,009 3,798 2.8 4,018 3.0

202001 138 147,165 4,022 2.7 4,028 2.7

202002 140 153,884 3,365 2.2 3,411 2.2

202003 140 155,275 3,293 2.1 3,667 2.4

202004 139 157,384 3,995 2.5 4,290 2.7

202005 139 159,950 4,351 2.7 4,646 2.9

202006 138 154,350 4,022 2.6 4,209 2.7

202007 138 153,379 3,956 2.6 4,009 2.6

202008 138 156,559 3,822 2.4 3,885 2.5

202009 139 153,328 3,228 2.1 3,259 2.1

202010 139 150,395 3,737 2.5 3,659 2.4

202011 140 143,241 5,050 3.5 4,575 3.2

202012 138 110,526 6,459 5.8 5,097 4.6

202013 138 86,781 5,058 5.8 3,371 3.9

202014 138 76,591 4,231 5.5 2,498 3.3

202015 137 71,087 3,335 4.7 1,719 2.4

202016 139 73,609 2,700 3.7 1,257 1.7

202017 139 79,380 2,696 3.4 1,154 1.5

202018 139 83,399 2,540 3.0 1,053 1.3

202019 140 86,300 2,356 2.7 989 1.1

202020 138 88,684 2,259 2.5 896 1.0

202021 137 93,874 2,298 2.4 1,099 1.2

202022 139 97,753 2,366 2.4 968 1.0

202023 140 103,053 2,430 2.4 1,018 1.0

Total 4,529,363 111,660 94,216




Reporting




Visits

201940 191 91,396 724 0.8 490 0.5

201941 188 91,937 715 0.8 499 0.5

201942 192 92,926 801 0.9 616 0.7

201943 188 92,049 792 0.9 575 0.6

201944 190 87,911 773 0.9 596 0.7

201945 191 89,314 927 1.0 744 0.8

201946 191 95,106 1,123 1.2 956 1.0

201947 194 95,335 1,125 1.2 1,059 1.1

201948 193 91,764 1,375 1.5 1,350 1.5

201949 193 98,038 1,453 1.5 1,353 1.4

201950 192 98,608 1,730 1.8 1,802 1.8

201951 193 99,591 1,985 2.0 2,240 2.2

201952 194 103,326 2,609 2.5 2,992 2.9

202001 194 104,125 2,311 2.2 2,462 2.4

202002 196 98,078 1,627 1.7 1,571 1.6

202003 193 92,646 1,367 1.5 1,283 1.4

202004 193 97,726 1,439 1.5 1,432 1.5

202005 194 96,957 1,694 1.7 1,714 1.8

202006 193 95,005 1,630 1.7 1,502 1.6

202007 197 96,714 1,567 1.6 1,482 1.5

202008 195 97,832 1,706 1.7 1,554 1.6

202009 195 98,129 1,891 1.9 1,711 1.7

202010 196 97,397 3,210 3.3 2,995 3.1

202011 195 92,796 4,627 5.0 3,898 4.2

202012 195 77,063 5,356 7.0 3,896 5.1

202013 197 62,890 4,118 6.5 2,417 3.8

202014 195 56,286 3,153 5.6 1,410 2.5

202015 194 56,813 2,403 4.2 1,001 1.8

202016 195 57,667 1,773 3.1 640 1.1

202017 194 61,420 1,622 2.6 626 1.0

202018 194 64,916 1,416 2.2 560 0.9

202019 196 67,300 1,165 1.7 445 0.7

202020 194 69,972 1,117 1.6 440 0.6

202021 194 71,494 1,020 1.4 403 0.6

202022 194 76,798 992 1.3 388 0.5

202023 196 76,200 933 1.2 372 0.5

Total 3,093,525 64,269 49,474


NCHS Mortality Surveillance Data For the Week Ending June 6, 2020 (Week 23)


Year Week Total Deaths Pneumonia, Influenza or

COVID-19 Deaths Baseline Threshold Number % of Total

2019 40 52,557 2,730 5.2 5.3 5.7 2019 41 53,083 2,799 5.3 5.4 5.7 2019 42 54,326 3,007 5.5 5.5 5.8 2019 43 54,037 3,027 5.6 5.6 5.9 2019 44 54,076 2,956 5.5 5.7 6.0 2019 45 55,679 3,108 5.6 5.8 6.2 2019 46 55,862 3,143 5.6 5.9 6.3 2019 47 56,165 3,062 5.5 6.0 6.4 2019 48 55,406 3,062 5.5 6.2 6.5 2019 49 57,278 3,427 6.0 6.3 6.6 2019 50 57,637 3,591 6.2 6.4 6.7 2019 51 57,403 3,511 6.1 6.5 6.8 2019 52 58,420 3,736 6.4 6.6 6.9 2020 1 59,801 4,489 7.5 6.7 7.0 2020 2 60,226 4,568 7.6 6.7 7.1 2020 3 58,784 4,460 7.6 6.8 7.2 2020 4 58,246 4,330 7.4 6.9 7.2 2020 5 57,789 4,214 7.3 6.9 7.3 2020 6 58,345 4,238 7.3 7.0 7.3 2020 7 57,691 4,298 7.5 7.0 7.3 2020 8 57,783 4,187 7.2 7.0 7.3 2020 9 58,163 4,390 7.5 7.0 7.3 2020 10 58,407 4,517 7.7 7.0 7.3 2020 11 57,279 4,505 7.9 6.9 7.3 2020 12 57,864 5,277 9.1 6.9 7.2 2020 13 61,745 8,062 13.1 6.8 7.1 2020 14 70,148 14,723 21.0 6.7 7.1 2020 15 76,431 20,339 26.6 6.7 7.0 2020 16 73,473 20,177 27.5 6.6 6.9 2020 17 69,001 17,490 25.3 6.5 6.8 2020 18 63,499 14,566 22.9 6.4 6.7 2020 19 60,745 13,045 21.5 6.3 6.6 2020 20 56,751 10,617 18.7 6.2 6.5 2020 21 50,187 7,797 15.5 6.0 6.4 2020 22 39,508 4,902 12.4 5.9 6.3 2020 23 19,763 1,445 7.3 5.8 6.2

key updates for week 23, ending june 6, 2020 virus › ... › pdf › covidview-06-12-2020.pdfjun...

Documents